The analysis of feedback regulation in yeast signal transduction pathways by Hao, Nan
THE ANALYSIS OF FEEDBACK REGULATION IN YEAST 
SIGNAL TRANSDUCTION PATHWAYS
Nan Hao
A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill 
in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the 
Department of Biochemistry and Biophysics, School of Medicine.
Chapel Hill
2006
Approved by
Advisor: Henrik Dohlman
Reader: Timothy Elston
Reader: Beverly Errede
Reader: Yue Xiong
Reader: David Siderovski
ii
ABSTRACT
NAN HAO: The analysis of feedback regulation in the yeast signal 
transduction pathways
(Under the direction of Henrik Dohlman)
The feedback loop is a ubiquitous regulatory motif that allows biological systems to 
dynamically control the intensity, duration and specificity of signal transduction. In yeast 
there are three interconnected mitogen-activated protein kinase (MAPK) signal 
transduction pathways controlling the mating pheromone response, the invasive growth 
response and the high osmolarity glycerol (HOG) response respectively. These parallel 
signaling pathways involve distinct MAPKs although they share some upstream 
components. Here we studied feedback regulation in each of these three yeast signal 
transduction pathways with the combinatorial use of experimental and computational 
analysis. We identified a novel negative feedback loop in the yeast pheromone pathway 
and a novel negative feedback loop in the yeast high osmolarity glycerol (HOG) response 
pathway, both of which contribute to regulation of signal intensity and duration. The 
feedback loop we identified in the pheromone pathway involves pheromone-dependent 
transcriptional induction of a regulator of G protein signaling (RGS) protein, Sst2, that 
accelerates GTPase activity of the G protein and contributes to signal termination. The 
feedback loop we discovered in the HOG response pathway is mediated by feedback 
iii
phosphorylation of the osmotic sensor Sho1 by mitogen-activated protein  kinase (MAPK) 
Hog1. Both of these two feedback regulations lead to signal desensitization. We also 
found a novel feedback loop that contributes to control the signal specificity between the 
pheromone pathway and the invasive growth pathway. The pheromone and invasive
growth pathways require distinct effector MAP kinases (Fus3 and Kss1, respectively) yet 
they are activated by a common set of upstream kinases (Ste11 and Ste7). We found that
phosphorylation of an intermediary MAP kinase kinase (Ste7) by Fus3 leads to selective 
inhibition of Kss1 and thus prevents cross-activation of the invasive growth pathway by 
pheromone.  
The analysis of feedback regulation in yeast might provide insights into the 
mechanism of signal desensitization and signal specificity control in higher eukaryotic 
organisms. The combination of experimental and computational approaches employed in 
our study could also be applied to other signaling pathways and other organisms, and 
promises to improve our understanding of how cellular changes in disease states can be 
predicted and managed.
iv
ACKNOWLEDGEMENTS
I am most grateful to my advisor, Dr. Henrik Dohlman. I could not complete the 
work included in this dissertation without his guidance. He not only taught me how to do 
biological experiments, but also trained me to think like a scientist and to capture the big 
scientific pictures in the field. This would definitely benefit me most in my future career. 
    All of the findings included in this dissertation are through the collaboration with Dr. 
Timothy Elston and his students, Dr. Necmettin Yildirim, Marcelo Behar and Xiao Wang
in the Department of Pharmacology, UNC-CH. I am very grateful to these kind 
collaborators and looking forward to continuing our unique and productive collaboration. 
Also I would like to thank my thesis committee, Dr. Beverly Errede, Dr. Yue Xiong
and Dr. David Siderovski for valuable advice and support.
     I would like to thank former member of Dohlman’s lab, Dr. Yuqi Wang for his 
valuable advice and experimental collaboration. He was always available to answer my 
questions and provide help.  
vTABLE OF CONTENTS
LIST OF TABLES ............................................................................................................................................. vii
LIST OF FIGURES.......................................................................................................................................... viii
CHAPTER 1. INTRODUCTION........................................................................................................................1
SIGNAL TRANSDUCTION IN EUKARYOTES ............................................................................................................1
SIGNAL TRANSDUCTIONS IN BUDDING YEAST ......................................................................................................2
YEAST PHEROMONE PATHWAY .............................................................................................................................3
YEAST HIGH OSMOLARITY GLYCEROL (HOG) RESPONSE PATHWAY .....................................................................6
YEAST INVASIVE GROWTH PATHWAY ...................................................................................................................8
NEGATIVE FEEDBACK REGULATION AND SIGNAL DESENSITIZATION.....................................................................9
POSITIVE FEEDBACK REGULATION AND BINARY RESPONSE................................................................................14
SWITCH-LIKE FEEDBACK REGULATION AND SIGNAL SPECIFICITY.......................................................................15
APPLICATION OF COMPUTATIONAL MODELING...................................................................................................17
SUMMARY AND PERSPECTIVE............................................................................................................................19
CHAPTER 2. NEGATIVE AND POSITIVE REGULATIONS OF THE YEAST PHEROMONE 
PATHWAY THROUGH RGS PROTEIN SST2...............................................................................................22
ABSTRACT.........................................................................................................................................................22
vi
INTRODUCTION .................................................................................................................................................23
RESULTS............................................................................................................................................................25
DISCUSSION ......................................................................................................................................................42
EXPERIMENTAL PROCEDURES ...........................................................................................................................46
CHAPTER 3. NEGATIVE FEEDBACK REGULATION OF THE YEAST OSMOTIC STRESS 
PATHWAY...........................................................................................................................................................54
ABSTRACT.........................................................................................................................................................54
INTRODUCTION .................................................................................................................................................55
RESULTS............................................................................................................................................................58
DISCUSSION ......................................................................................................................................................74
EXPERIMENTAL PROCEDURES ...........................................................................................................................79
SUPPLEMENTAL DATA........................................................................................................................................86
CHAPTER 4. REGULATION OF MAPK SIGNALING FIDELITY BY FEEDBACK
PHOSPHORYLATION .....................................................................................................................................97
ABSTRACT.........................................................................................................................................................97
INTRODUCTION .................................................................................................................................................97
RESULTS..........................................................................................................................................................100
DISCUSSION ....................................................................................................................................................110
EXPERIMENTAL PROCEDURES .........................................................................................................................112
REFERENCES .................................................................................................................................................115
vii
LIST OF TABLES
TABLE 1 .................................................................................................................................................................26 
TABLE S1 ...............................................................................................................................................................93 
TABLE S2 ...............................................................................................................................................................94 
TABLE S3 ...............................................................................................................................................................95 
TABLE S4 ...............................................................................................................................................................96 
viii
LIST OF FIGURES
FIGURE 1.1...............................................................................................................................................................4
FIGURE 2.1.............................................................................................................................................................27 
FIGURE 2.2.............................................................................................................................................................29
FIGURE 2.3.............................................................................................................................................................31 
FIGURE 2.4.............................................................................................................................................................33 
FIGURE 2.5.............................................................................................................................................................34 
FIGURE 2.6.............................................................................................................................................................36 
FIGURE 2.7.............................................................................................................................................................38
FIGURE 2.8.............................................................................................................................................................39
FIGURE 2.9.............................................................................................................................................................41 
FIGURE 3.1.............................................................................................................................................................59
FIGURE 3.2.............................................................................................................................................................64 
FIGURE 3.3.............................................................................................................................................................66 
FIGURE 3.4.............................................................................................................................................................69
FIGURE 3.5.............................................................................................................................................................73 
FIGURE 3.6.............................................................................................................................................................77 
FIGURE 3.S1...........................................................................................................................................................88
FIGURE 3.S2...........................................................................................................................................................90 
FIGURE 3.S3...........................................................................................................................................................91 
FIGURE 4.1...........................................................................................................................................................101
ix
FIGURE 4.2...........................................................................................................................................................101
FIGURE 4.3...........................................................................................................................................................107
FIGURE 4.4...........................................................................................................................................................109
CHAPTER 1. INTRODUCTION
Signal transduction in eukaryotes
One fundamental question in biology is how cells respond to external cues. One aspect 
of this question is cell adaptation to their environment. Certain environmental changes, such 
as a sudden increase of external temperature or deprivation of nutrient resources, may 
severely threaten cell survival. The capability of sensing dangerous situations and eliciting 
proper adaptation behaviors enable cells to live in versatile external conditions. A second
aspect is cell-cell communication. Cell communication enables one cell to influence the 
behavior of other cells. In this way, a group of unicellular organisms can cooperate in some 
sophisticated social behaviors or a multicellular organism can govern the behavior of each 
individual cell for the benefit of the organism as a whole. Efficient communication depends 
on the signal molecules secreted from one cell into the environment that can be detected and 
responded to by other cells.  
For decades, the mechanisms of how cells respond to external signals have been widely 
investigated. It has been found that cells utilize elaborate systems of proteins to respond to 
extracellular stimuli. These systems start with a transmembrane sensor or receptor proteins 
that can sense the environmental change or bind to extracellular signal molecules and then 
initiate a response by altering the conformation and/or activity of a variety of intracellular 
proteins with which they interact. These intracellular proteins either induce the production of 
2small signaling molecules, such as cyclic AMP, or alter the conformation or/and activity of 
certain downstream intracellular proteins to transmit the signal appropriately inside the cell. 
At the end, the activities of some specific target proteins are altered by these intracellular 
proteins or small molecules. The resulting alterations in target proteins will change or induce 
specific cellular behaviors. In this way, a cell is able to execute specific behaviors in response 
to specific environmental stimuli. The systems of proteins that sense and transmit the signal 
are called signal transduction pathways.
Signal transductions in budding yeast
For decades people have utilized the budding yeast Saccharomyces cerevisiae not only 
in baking and brewing but also in scientific research of signal transductions. Budding yeast is 
a simple unicellular eukaryote. Compared with the other eukaryotic systems utilized in 
biological studies, such as those of fruit flies and mice, genetic manipulation in yeast is by far 
the easiest because yeast cells can exist in stable haploid form and have a high rate of DNA 
homologous recombination. The relatively short period of the yeast life cycle makes it an 
economical system for biochemistry studies as well. Moreover, besides the completion of the 
whole yeast genome sequence project, recently 3 yeast libraries have been constructed: 
non-essential gene deletion mutant library, TAP tagged yeast protein library (Ghaemmaghami, 
Huh et al. 2003) and GFP tagged yeast protein library (Huh, Falvo et al. 2003). All these 
libraries greatly facilitate the biological research. For example, the experimental data about 
the expression and localization of most of the yeast proteins have been obtained using these 
3libraries.  
The signal transduction pathways are highly conserved in eukaryotes from yeast to 
human beings. Budding yeast is a powerful tool for the study of signal transduction. There 
are three typical and related signal transduction pathways in yeast, which I investigated 
during my Ph.D study (Fig 1.1). 
Yeast pheromone pathway 
The yeast pheromone pathway is arguably the best characterized signal transduction 
pathway in all eukaryotes. It mediates the yeast mating response and has long served as a 
prototype for hormone, neurotransmitter and sensory signal transduction pathways in humans 
(Dohlman and Thorner 2001). Two types of yeast haploid cells, MATa-type and MAT-type 
exist in nature. The MATa-type cells secrete a short peptide, a-factor mating pheromone that 
can be detected by MAT–type cells while MAT–type cells secrete –factor mating 
pheromone that can be detected by MATa-type cells. The mating events are initiated by the 
binding of mating pheromone to the G protein-coupled receptors (GPCRs) of the opposite 
type of haploid cells. GPCRs are the seven-transmembrane receptor proteins coupled with 
heterotrimeric G proteins (G) (Blumer and Thorner 1991). Upon pheromone binding, the 
receptors (named Ste2 in a-type yeast cells and Ste3 in -type yeast cells) catalyze the 
exchange of GDP to GTP on the coupled G subunit (Gpa1 in yeast). As a result, G-GTP 
will dissociate from G (G named Ste4 and G named Ste18 in yeast). Free G-GTP and 
G will activate various downstream effectors, leading to the execution of the mating 
4Fig 1.1.Three signal transduction pathways in Saccharomyces cerevisiae share components in 
common.
This is a simplified schematic representative. Not all known pathway components have been shown. 
See text for details and other abbreviations.
5response. G has intrinsic GTPase activity and therefore can hydrolyze GTP. When GTP is 
hydrolyzed to GDP, G-GDP re-associates with G and thereby the signal is terminated.
One effector of G is Cdc24, a guanine exchange factor (GEF) of small Ras-like G 
protein Cdc42 (Zheng, Cerione et al. 1994). Cdc42 controls the polarization of cell growth 
and morphogenesis. Free G interacts with Cdc24 via a scaffold protein Far1 (Chang and 
Herskowitz 1990). In the absence of pheromone, Far1 bound with Cdc24 is sequestered in 
the nucleus; upon exposure to pheromone, Far1 ferries Cdc24 into cytosol and forms the 
Ste4/18(G)-Far1-Cdc24 complex at the membrane positioned towards pheromone 
gradients (Blondel, Alepuz et al. 1999). The complex formation mediates efficient and highly 
localized generation of Cdc42-GTP. Cdc42-GTP thereby induces change of the cytoskeleton 
leading to polarized cell growth towards the closest yeast mating partner. Cdc42 can also 
regulate the kinase cascade and gene transcription in the pathway by interaction with 
p21-activated protein kinase (PAK) Ste20 (Leberer, Wu et al. 1997; Leeuw, Wu et al. 1998). 
Far1 also acts as an inhibitor of cyclin-dependent kinase (CDK) Cdc28 in the nucleus and 
thereby mediates pheromone-induced G1 growth arrest (Chang and Herskowitz 1990; 
Gartner, Jovanovic et al. 1998). 
Another major target of G is the mitogen-activated protein kinase (MAPK) cascade. 
In this cascade, MAPK kinase kinase Ste11 (Rhodes, Connell et al. 1990) is activated upon 
binding to free G and kinase Ste20. Activated Ste11 phosphorylates and activates MAPK 
kinase Ste7 (Neiman and Herskowitz 1994). Activated Ste7 phosphorylates and activates 
MAPK Fus3 and Kss1 (Gartner, Nasmyth et al. 1992; Errede, Gartner et al. 1993). Ste11, 
6Ste7 and Fus3 bind to a scaffold protein Ste5 (Choi, Satterberg et al. 1994). Free G can 
also bind and has been proposed to change the conformation of Ste5 leading to its activation 
(Sette, Inouye et al. 2000). This scaffold protein would allow more efficient signaling and 
possibly contribute to keeping signal specificity. The major substrates of MAPK Fus3 in 
nucleus are transcriptional factor Ste12 (Elion, Satterberg et al. 1993) and inhibitors of Ste12, 
Dig1/2 (Cook, Bardwell et al. 1996). Ste12 and Dig1/2 form heterodimers in normal cells. 
Upon pathway activation, Fus3 phosphorylates Ste12 and Dig1/2 and this phosphorylation 
disrupts the association between Ste12 and Dig1/2. Phosphorylated Ste12 further forms 
homodimers and activates the transcription of a specific set of genes under promoters 
containing the pheromone-responsive element (PRE) (Kronstad, Holly et al. 1987). The 
transcription induction of these genes is required for appropriate execution of the mating
response (Hagen, McCaffrey et al. 1991). 
In summary, the yeast mating response includes polarized cell growth towards a mating 
partner, G1 growth arrest, and transcription induction of a series of genes, which finally leads 
to the successful fusion of MATa-type and MAT-type cells into a diploid cell. All these 
elaborate cellular behaviors are controlled by signal transduction of yeast pheromone 
pathway.
Yeast high osmolarity glycerol (HOG) response pathway 
External high osmolarity stimulates at least two putative membrane-bound osmosensing 
proteins in yeast, Sho1 and Sln1, both of which lead to the activation of MAPK kinase Pbs2 
7and MAPK Hog1. Sln1 is an integral membrane protein and, together with Ypd1-Ssk1, is
homologous to bacterial two-component signal transducers. Upon stress stimulation,
Sln1-Ypd1-Ssk1 activates two partially redundant kinases (Ssk2 and Ssk22), which then 
activate the MAPK kinase Pbs2 and ultimately MAPK Hog1. The second osmosensor Sho1 
binds and activates a distinct MAPK kinase kinase Ste11, which then activates Pbs2 and 
ultimately Hog1. Ste11 also works as a MAPK kinase kinase in the pheromone pathway.
Specifically Sho1 and Sln1 work as stress sensors, rather than osmosensing receptors 
since they respond to a wide range of distinct chemical substances and temperature changes. 
The activation of Hog1 by Sho1 is unusually transient, while activation by Sln1 is more 
persistent. I focused my study in the Sho1 branch because this branch shares several pathway 
components with the pheromone pathway. 
Sho1 has many characteristics of a scaffold protein. It binds with MAPK kinase kinase 
Ste11 and MAPK kinase Pbs2. Although Pbs2 is shown to function as a scaffold to recruit 
Ste11 and Hog1 into a cascade complex, the interaction of Sho1 with Ste11 and Pbs2 is 
required for efficient activation of Pbs2 by Ste11. Moreover, as in the pheromone pathway, 
Ste11 in the HOG pathway is also activated by PAK Ste20. As mentioned previously, 
Cdc42-GTP binds to Ste20. Sho1 has also been shown to localize at bud tips, as well as 
Cdc42, and recruit Ste11 at bud tips to be activated by Ste20. 
Hog1 helps cells to adapt to external stress conditions by activating the transcription of a 
series of specific genes. Among these genes, GPD1/2 encodes NAD-dependent 
glycerol-3-phosphate dehydrogenases, the key enzymes of glycerol synthesis. By activating 
8the transcription of GPD1/2, Hog1 induces the increased production of glycerol that serves to 
equalize cellular osmotic pressure with the external environment so that cells could adapt to 
osmotic stress conditions. 
Yeast invasive growth pathway
The yeast invasive (or filamentous) growth pathway is not as well characterized as the 
above two pathways. This pathway is activated in nutrient-poor conditions and causes 
increased cellular adherence to and invasiveness of the substratum (haploids) or the 
formation of long branching filaments (diploids) in the search for nutrients. How yeasts sense 
the nutrient limitation is not known. However, it has been shown that the invasive growth 
pathway shares a significant fraction of pathway components, from G (Ste4/Ste18) to 
MAPK kinase Ste7, with the yeast pheromone pathway (Andersson, Simpson et al. 2004). 
MAPK Kss1, which is also activated by pheromone and contributes to the full activation of 
the mating response, is the specific and essential MAPK for invasive growth. Transcription 
factor Ste12 is also utilized by this pathway to induce transcriptions of a series of genes. 
However, upon activation of the invasive growth pathway, Ste12 no longer forms a 
homodimer; instead it forms a heterodimer with another invasive growth pathway specific 
transcription factor Tec1. The Ste12-Tec1 heterodimer can recognize a 
filamentation-responsive element (FRE) in DNA promoter regions and induce the 
transcription of the genes under these FRE promoters (Baur, Esch et al. 1997; Madhani and 
Fink 1997). 
9Negative feedback regulation and signal desensitization
One universal phenomenon in biology is that the continuous external stimulation leads 
to a diminishing cellular response over time. This phenomenon, termed desensitization, 
occurs in our daily life. For example, strong odor becomes unnoticeable upon chronic 
exposure. The loss of responsiveness also limits the effective lifetime of therapeutic drugs 
and, therefore, is a major problem of the continued administration of drugs. 
Desensitization generally results from negative feedback regulation, where a 
downstream effector attenuates the activity of an upstream transducer, thereby inhibiting
further activation of the pathway. The desensitization can occur as fast as in seconds or as 
slowly as in days. The time scale of desensitization depends on the inhibitory mechanisms. 
The long-term feedback inhibition involves mechanisms that take hours or days. One 
example comes from our study in Chapter 2 about the negative feedback regulation of the 
yeast pheromone pathway by regulator of G protein signaling (RGS) protein, Sst2. As 
mentioned above, the yeast pheromone pathway controls the mating response. The pathway
is activated once a yeast cell detects the mating pheromone peptide secreted by a mating 
partner. Upon the pathway activation, the yeast cell stops cell division and undergoes 
morphological changes in preparation for mating. If in certain circumstances the yeast cell 
fails to mate, it will desensitize and recover from growth arrest and resume proliferation 
despite the continuous presence of mating pheromone. Since the mating process may take 
several hours to complete, this desensitization may involve long-term feedback inhibition 
10
mechanisms. 
One major mechanism of pheromone signaling desensitization is through the yeast 
prototype RGS protein Sst2. Discovery of the key role of RGS proteins in G-protein 
signaling desensitization was first made in the budding yeast. The yeast gene SST2 was 
identified in a screen for mutants that interfere with pheromone adaptation (Chan and Otte 
1982; Chan and Otte 1982). A family of proteins homologous to Sst2 was subsequently 
discovered in more complex organisms. The function of Sst2 has been thoroughly 
characterized. It was shown that Sst2 interacts genetically (Dohlman, Apaniesk et al. 1995; 
DiBello, Garrison et al. 1998) and physically with yeast G Gpa1 (Dohlman, Song et al. 
1996) and works as a potent GTPase Accelerating Protein (GAP) for G proteins (Berman, 
Wilkie et al. 1996; Apanovitch, Slep et al. 1998). These findings, together with an X-ray 
crystal structure determination of the mammalian Gi1-RGS4 complex (Tesmer, Berman et al. 
1997), provide the mechanism by which RGS proteins promote desensitization: By 
stimulating G GTPase activity, RGS shortens the lifetime of the active G GTP-bound 
species, accelerates reassociation with G, and attenuates the cellular response.
Activation of the pheromone pathway stimulates the transcription factor Ste12 and 
induces transcription of a group of new genes. The gene encoding the RGS protein Sst2 is 
one of the pheromone-induced genes. As mentioned above, Sst2 accelerates GTPase activity 
of G Gpa1 and mutants lacking SST2 are more sensitive to pheromone. This pattern of 
induction and regulation of pheromone signaling suggests that the induction of Sst2 
expression is part of a negative feedback loop that promotes desensitization. Although 
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intuitively reasonable, this concept had never been tested explicitly. In Chapter 2, we studied 
and confirmed the importance of negative feedback inhibition through induction of Sst2 
expression (Hao, Yildirim et al. 2003). A number of other negative regulators are also 
transcriptionally induced by pheromone including the MAPK phosphatase Msg5 (Roberts, 
Nelson et al. 2000). The mechanisms involve increased transcription of negative regulators 
that could severely limit the duration of pathway activation but would occur over the 
relatively long time needed for new protein synthesis.   
Long-term feedback inhibition in the pheromone pathway also involves the 
counter-regulatory event of induced protein synthesis of negative regulators, namely the 
accelerated degradation of activators or transducers. This regulated protein degradation is 
controlled by a post-translational protein modification, called ubiquitination. Ubiquitin is a 
76-amino acid protein, which is highly conserved in all eukaryotes. The conjugation of 
ubiquitin to other cellular proteins has a well-documented role in targeting proteins for 
degradation by the proteasome (Pickart 2001). The kinase effectors of the pheromone 
pathway, MAPK kinase kinase Ste11 (Esch and Errede 2002) and MAPK kinase Ste7 (Wang 
and Dohlman 2002) were found to be regulated by pheromone-dependent ubiquitination and 
degradation. The functional analysis of Ste7 ubiquitination suggests that Ste7 is the limiting 
component of pheromone MAPK cascade. Thus, ubiquitination, which leads to rapid 
degradation of Ste7 and Ste11, contributes to signal desensitization. 
Short-term feedback inhibition does not involve mechanisms requiring new protein 
synthesis or degradation and, therefore, acts rapidly within seconds or minutes of pathway 
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activation. In Chapter 3, we studied the short-term feedback inhibition mediated by 
Hog1-dependent phosphorylation of osmotic sensor Sho1 in the HOG response pathway. As 
mentioned previously, this pathway allows yeast to adapt to high osmotic condition by 
activating a MAPK cascade, culminating at MAPK Hog1 (O'Rourke SM 2002; Westfall PJ 
2004). There are two branches (mediated by Sho1 and Sln1) of this pathway, both of which
lead to the activation of MAPK kinase Pbs2 and MAPK Hog1. We focused our study on the
Sho1 branch of pathway because the activation of MAPK Hog1 by this branch is unusually 
transient. In the pheromone signaling pathway, the prolonged MAPK Fus3 activation, which 
is peaked in 30 minutes and returned to basal level in 2 hours, is required for the appropriate 
execution of the mating response. However, in the HOG response pathway the transient 
activation of MAPK Hog1, which is peaked in 5 minutes and returned to basal level in 30 
minutes, is enough to produce glycerol, that serves to equalize cellular osmotic pressure with 
the external environment and, thereby, helps cells to adapt to high osmotic environment 
(Hohmann 2002). On the other hand, the constitutive activation of Hog1 will cause 
overproduction of intracellular glycerol and lead to cell death. Therefore, the transient 
dynamics of Hog1 activation is not only sufficient but also necessary for cell survival under 
high osmotic stress condition (Hohmann 2002). 
Investigation of the underlying mechanisms leading to transient pathway activation has 
been focused on feedback inhibition through phosphorylation, which provides a rapid and 
reversible means for the dynamic control of signal transduction. In Chapter 3, we discovered 
phosphorylation of osmotic sensor Sho1, which is stimulated by osmotic stress and Hog1 
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dependent. This phosphorylation promotes the transition of Sho1 from oligomeric to 
monomeric form and diminishes the further activation of Hog1 through Sho1. The MAPK 
dependent feedback phosphorylation of upstream components can occur in minutes via a 
single biochemical reaction without the involvement of gene transcription, protein synthesis 
or degradation. Therefore, the transient cellular responses are generally controlled by 
feedback phosphorylation mechanisms.
In any signal transduction pathway there might be multiple overlapping mechanisms of 
desensitization, each with distinct kinetics of induction that collectively modulate cellular
responsiveness to a given stimulus. For example, in the yeast pheromone pathway, where 
the desensitization mechanisms always involve long-term feedback inhibitions, MAPK Fus3 
has also been shown to feedback-phosphorylate RGS protein Sst2 (Parnell SC 2005 ), 
scaffold protein Ste5 (Flotho A 2004) and MAPK kinase Ste7 (Errede, Gartner et al. 1993; 
Zhou, Gartner et al. 1993; Maleri, Ge et al. 2004). These feedback phosphorylations are 
thought to contribute to the regulation of some early steps of the prolonged mating response. 
On the other hand, in the HOG response pathway, where the desensitization mechanisms 
always involve short-term feedback phosphorylation, the negative signaling regulators, Ptp2 
and Ptp3, which are the phosphatases of MAPK Hog1, have been shown to be 
transcriptionally induced by osmotic stress stimulation (Wurgler-Murphy, Maeda et al. 1997). 
This long-term feedback inhibition contributes to cell survival under high salt condition. 
Taken together, various distinct short-term and long-term desensitization mechanisms always 
coordinate in one signal transduction pathway to provide dynamic regulation of the 
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sequential cellular events in response to a specific stimulus. 
Positive feedback regulation and binary response
Contrary to negative feedback regulation, positive feedback regulation occurs when a 
downstream effector enhances the activity of upstream components and thereby promotes its 
own activation. The study of positive feedback regulation in signal transductions is crucial 
for understanding biological behaviors such as the cell fate decision during differentiation, 
signal amplification, and ultra-sensitivity of signal transductions. 
One oft-cited example of the cell fate decision process is Xenopus oocyte maturation. In 
response to the steroid hormone progesterone, an oocyte cell may either undergo maturation 
and arrest in metaphase of meiosis II or fail to mature and remain arrested in a G2 state. It 
cannot stay in an intermediate state. Moreover, once an oocyte has matured, it will remain in 
mature state even after the progesterone is removed. Therefore, the oocyte maturation, like 
other cell fate decision processes, is an all-or-none, irreversible process (Ferrell and Xiong 
2001). It has been proposed and proved that this all-or-none character and irreversibility arise 
out of the existence of two steady states, a phenomenon  known as bistability or binary 
response, of the signaling transduction systems that mediate the maturation and that this 
binary response occurs through positive feedback regulations of p42 MAPK/Cdc2 system in 
oocyte signaling transduction (Xiong and Ferrell 2003). 
The yeast mating response is also a cell fate decision process. Pheromone activation 
converts yeast cells from vegetative growth state into enlarged shmooed state, arrested in G1. 
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The growth arrest and morphological change is pseudo-irreversible because the resumption 
of vegetative growth requires several days. In Chapter 2, we studied the binary response of 
the pheromone signaling pathway and the positive feedback regulation that might account for 
this bistability behavior. We observed an RGS protein Sst2-dependent binary response of 
pheromone-dependent transcriptional induction. This cellular behavior possibly occurs 
through an Sst2-dependent positive feedback regulation, which was subsequently found to be 
a pheromone-promoted ubiquitination and degradation of RGS protein Sst2. Further
investigation demonstrated that this binary response is transient and dependent on the 
incubation time and dose of pheromone treatment.     
Switch-like feedback regulation and signal specificity
An external stimulus will induce a distinct response in cells. Inappropriate activation of 
a response will cause severe diseases, like human cancer (Hanahan and Weinberg 2000). 
Cells utilize a limited number of intracellular signaling proteins to transduce a wide 
variety of external signals and elicit specific cellular responses, so that different signal 
transduction pathways are often interconnected and share the same intermediate components. 
The mechanisms to maintain specificity from signal to response are poorly understood. 
In yeast, there are three parallel MAPK pathways that transmit different signals. As 
mentioned above, the pheromone mating pathway is initiated by pheromone, transmits the 
signal through MAPK Fus3, and induces the mating response. The invasive growth pathway 
is activated in response to nutrient limitation, transmits the signal through MAPK Kss1, and 
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induces the invasive growth response. The osmolarity response pathway is stimulated by 
osmotic stress, transmits the signal through MAPK Hog1, and induces the adaptation to 
osmotic stress. These three pathways are initiated by different external stimuli, transmit via 
different MAPKs, and induce different cellular responses; but they share the same signal 
transducer MAPK kinase kinase Ste11, upstream of MAPK. Furthermore, the pheromone 
response pathway and the invasive growth pathway share the same MAPK kinase Ste7.
A recently discovered switch-like regulation in the yeast pheromone pathway is 
pheromone-regulated sumoylation (Wang and Dohlman 2006) and ubiquitination (Bao, 
Schwartz et al. 2004; Chou, Huang et al. 2004) of transcription factors. Although the 
pheromone pathway and the invasive growth pathway utilize different MAPKs, Fus3 and 
Kss1, they share the same downstream transcription factor Ste12, which interprets the signal 
that the kinases transmit and initiates transcription of a different set of genes. Ste12-Ste12 
forms homodimers to promote the transcription of genes required for the mating response. 
Ste12-Tec1 heterodimers induce genes required for the invasive growth response. It has been 
found that the pheromone stimulation promotes Ste12 sumoylation and inhibits Tec1 
sumoylation. Without symoylation, Tec1 is rapidly degraded. In this way, pheromone
activation of the pathway diminishes the formation of Ste12-Tec1 heterodimers and the 
expression of invasive growth -responsive genes. At the same time, the pheromone treatment 
promotes the formation of Ste12-Ste12 homodimers and the expression of mating responsive 
genes. This mechanism underlies a developmental switch from invasive growth to the mating 
response.
17
In Chapter 4, we investigated the mechanism involved in the signal specificity 
regulation between the pheromone response pathway and the invasive growth pathway. 
Particularly we focused on MAPK level of specificity regulation. It has been shown that 
active Fus3 can inhibit Kss1 activation upon pheromone stimulation and therefore limit 
misactivation of the invasive growth pathway in response to pheromone. In Chapter 4, we 
studied the mechanism underlying Fus3-dependent inhibition of Kss1 in response to 
pheromone. We found that Fus3 can feedback-phosphorylate MAPK kinase Ste7 and limit 
Ste7’s ability to activate Kss1. This feedback regulation works like a switch to turn off the 
signal flow to Kss1 activation and the invasive growth response, while also elevating the 
Fus3 activation and the mating response. 
Application of computational modeling 
To understand the signal transduction networks in cells as an integrated system, the 
power of computers would be extremely helpful to analyze the huge amount of experimental 
data generated with high-throughput technologies. The computational and mathematical 
modeling techniques could enable us to understand and predict important aspects of the 
behavior of biological systems. It is an exciting and vitally important opportunity for 
medicine and biology. 
In our study, the computational analysis of signal transduction pathways not only 
suggested directions leading to new biological discoveries but also provide d insights into 
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some biological behaviors that c ould not be explained intuitively. 
In Chapter 2, we initially constructed a computational model of G protein cycle in the 
yeast pheromone pathway based on the published literature and established knowledge. The 
functional effect of genetic perturbations of the pathway was examined experimentally and 
compared with the model predictions. The initial model failed to capture some features of the 
experimental data. Unknown possible regulations in the pathway were considered to 
reconcile the discrepancies between actual data and model predictions. Further experiments 
confirmed the new regulation, which is a positive feedback loop leading to RGS degradation. 
Moreover, another related observation was the binary response of the pheromone pathway. A 
simple qualitative stochastic model helped us to understand how the binary response occurs 
via a positive feedback loop, which may not be intuitive for biologists. This model-oriented 
approach prompted our discovery and understanding of new biological regulations in signal 
transduction networks.
In Chapters 3 and 4, computational modeling helped us in a slightly different way. 
Here the existence of a missing regulation was obvious without utilization of modeling. 
However, the mechanism of the regulation remained unknown. In Chapter 3, it has been 
shown that MAPK Hog1 feedback inhibits its own activation upon osmotic stress stimulation. 
But which component in the pathway that is feedback-inhibited by Hog1 had not been shown. 
In Chapter 4, it has been found that the pheromone MAPK Fus3 can inhibit activation of the 
invasive MAPK Kss1 upon pheromone treatment and that this inhibition depends on Fus3 
kinase activity. But the mechanism of this inhibition had not been shown. It would be very 
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time and labor-consuming to test all the possible mechanisms experimentally. In order to 
accelerate this process, we constructed several simple computational models. Each model 
represented a possible mechanism of the missing regulation and was evaluated for its ability 
to reproduce the new experimental data and for consistency with previously published 
experimental observations. In this way one set, instead of several different sets, of 
experimental data was generated to test all the possible mechanisms. The best one or two 
mechanisms picked up by modeling were further investigated experimentally. This approach 
helped us to focus our time and resources in the right direction.
Summary and Perspective
The following is a summary of our work in the feedback regulations of signal 
transduction. 
In Chapter 2, we first proved the importance of the negative feedback loop through 
induction of the RGS protein Sst2. The second finding was the binary response of the yeast 
pheromone pathway. In order to explain the source of the binary response, we discovered the 
positive feedback loop via induction of Sst2 ubiquitination and degradation, which might 
lead to resensitization of the pathway. During the work, we also constructed a computational 
model to describe the G protein signaling in yeast.
In Chapter 3, we made a series of discoveries. First, we determined that Sho1 is 
phosphorylated by Hog1. Sho1 is the first upstream component of the osmotic 
stress-response pathway identified as a substrate for Hog1. Second, we determined that Sho1 
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exists normally as a homo-oligomer. Third, we determined that phosphorylation leads to a 
loss of Sho1 oligomerization and a diminishing signal. We also constructed a simple 
computational model based on the newly discovered feedback regulation; this model can 
reproduce most of our experimental results.
In Chapter 4, we found that phosphorylation of an intermediary MAP kinase kinase 
Ste7 by Fus3 leads to selective inhibition of Kss1 and the invasive growth pathway. This
mechanism underlies a specificity switch to prevent crosstalk from the mating response to the 
invasive growth. We also constructed a predictive computational model based on the newly
discovered feedback regulation.
The long-term goal of our study is to provide insight into the mechanisms of signal 
regulation in higher eukaryotes and eventually guide the development of new therapies for 
human diseases. The studies in Chapters 2 and 3 demonstrated new targets of signal 
desensitization and therefore might be a stepping stone on the path to understanding and 
preventing drugs from loss of effectiveness over time. The mis-activation of inappropriate 
cellular response, caused by loss of signal specificity, might lead to human cancers. The 
study in Chapter 4 demonstrated that mutation of one or several key residues (feedback 
phosphorylation sites) of a signal transducer might lead to a significant mis-activation of 
signal transduction. This discovery might broaden our understanding of tumorigenesis and 
motivate the search for new targets of anti-c ancer therapies. 
The other significance of our study is that we utilized computational modeling in our 
investigations. This work demonstrates how computational and experimental approaches, 
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used in an integrated fashion, can determine the basis for signaling pathway regulations in 
vivo. The long-term goal is that by quantifying biological systems and accurately predicting 
cellular processes, we could eventually test the effect of novel pharmaceutical drugs or 
clinical treatments to various diseases using computational simulations of human signal 
transductions. This will radically accelerate the development of modern medicines. The first 
important step of this endeavor would be to model the signal transduction networks in the 
simplest eukaryote Saccharomyces cerevisiae. We studied the three best-characterized signal 
transduction pathways in yeast. Only by modeling this type of well-understood pathways in 
yeast successfully could we possibly devise models of the more complex biological pathways 
in higher organisms and finally the most sophisticated metabolic and signaling networks in 
humans. All of the models constructed in our study could serve as tools for the computational 
modeling of signal transduction in higher organisms.
CHAPTER 2. NEGATIVE AND POSITIVE REGULATIONS OF 
THE YEAST PHEROMONE PATHWAY THROUGH RGS 
PROTEIN SST2
Abstract
Cellular responses to hormones and neurotransmitters are necessarily transient.  The 
mating pheromone signal in yeast is typical.  Signal initiation requires cell surface receptors, 
a G protein heterotrimer and downstream effectors.  Signal inactivation requires Sst2, a 
regulator of G protein signaling (RGS) protein that accelerates GTPase activity.  We 
conducted a quantitative analysis of RGS and G protein expression, and devised 
computational models that describe their activity in vivo.  These results indicate that 
pheromone-dependent transcriptional induction of the RGS protein constitutes a negative 
feedback loop that leads to desensitization.  Modeling also suggests the presence of a 
positive-feedback loop leading to resensitization of the pathway.  In confirmation of the 
model, we find that the RGS protein is ubiquitinated and degraded in response to pheromone 
stimulation.  Identification and quantitation of these positive and negative feedback loops 
account for the transient response to external signals observed in vivo.
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Introduction
One measure of our understanding of biological systems is our ability to predict their 
behavior in detail.  One aspect of this endeavor is to model signal transduction events, 
defined here as the dynamic changes that occur within a cell in response to an external 
stimulus (Riccobene, Omann et al. 1999; Shea, Neubig et al. 2000; Bhalla, Ram et al. 2002).  
Such models can help us to understand how small changes outside a cell produce strongly 
amplified changes within a cell, how graded signals are converted to all-or-none responses 
(Ferrell and Machleder 1998), or how activators of one pathway influence the function of a 
second pathway (Bhalla and Iyengar 1999).  A second goal, and the focus of this work, is to 
understand how transient external signals are prevented from being propagated indefinitely 
within the cell.  Here we describe the molecular basis for signal activation, desensitization, 
and eventual resensitization of G proteins by receptors and RGS proteins.  The 
experimentally observed behavior is described mechanistically by computational modeling of 
the pathway.
For these studies we investigate the mating pheromone signaling pathway in yeast 
Saccharomyces cerevisiae.  The yeast mating response is arguably the best-characterized 
signal transduction pathway of any eukaryote, and it has long served as a prototype for 
hormone, neurotransmitter and sensory response systems in humans (Dohlman and Thorner 
2001).  Disruption or activation of pathway components leads to highly specific changes 
that can be easily quantified.  Finally, because it is a unicellular eukaryote, every cell in a 
population is genetically and phenotypically identical (all cells are 'typical').
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Mating in yeast is the fusion of a and  haploid cell types to form an a/ diploid.  The 
events leading to fusion are initiated by specific pheromones:  -type cells secrete -factor 
pheromone, which binds to a specific receptor (Ste2) on a-cells, while a-cells secrete a-factor 
that binds to receptors (Ste3) on -cells.  Upon pheromone binding to its receptor, the G 
protein  subunit (Gpa1) releases GDP, binds to GTP, and liberates the G protein  subunits 
(Ste4/Ste18).  Sustained signaling requires multiple effectors that bind to the dissociated G
(Guo, Aston et al. 2003) and G components (Dohlman 2002).  These effectors go on to 
activate a mitogen-activated protein (MAP) kinase cascade, leading to new gene transcription, 
morphological changes, cell division arrest and ultimately cell fusion to form the a/ diploid 
(Dohlman and Thorner 2001).  Following GTP hydrolysis, the G protein subunits 
reassociate and signaling stops (Neves, Ram et al. 2002).
One of the pheromone-induced genes encodes the prototype RGS protein Sst2.  We 
showed previously that Sst2 interacts genetically (Dohlman, Apaniesk et al. 1995; DiBello, 
Garrison et al. 1998) and physically (Dohlman, Song et al. 1996) with Gpa1, and can 
accelerate its GTPase activity more than 40-fold (Apanovitch, Slep et al. 1998).  Mutants 
lacking SST2 are ~100 fold more sensitive to pheromone (Chan and Otte 1982; Chan and 
Otte 1982; Dohlman, Song et al. 1996).  This pattern of induction and regulation of 
pheromone signaling suggests that Sst2 is part of a feedback inhibition loop that promotes 
desensitization.  Although intuitively reasonable, this concept has never been tested 
explicitly.  Moreover, while computational models of G protein activation and inactivation 
have been devised previously, they have not been rigorously tested in vivo due to a lack of 
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information about expression levels or about specificity of coupling of receptors and G 
proteins (Shea and Linderman 1997; Shea, Neubig et al. 2000).  Here we devise a detailed 
model that describes the behavior of cells treated with pheromone, and demonstrate the 
predictive power of that model through experimentation.
Results
Our goal in this work was to understand how external signals produce responses within 
the cell.  Our focus was on G protein activation, desensitization, and eventual resensitization 
by receptors and RGS proteins.  Since an accurate model of any biological system requires 
knowledge of the identity and quantity of its components, we began by determining the 
amount of the RGS (Sst2) and G (Gpa1) present in the cell.  The G subunits Ste4 and 
Ste18 were presumed to be expressed at levels equal to Gpa1, since G protein subunits 
assemble in a 1:1:1 stoichiometry, and Ste4 and Ste18 do not bind to any other G in yeast.  
Receptor expression was determined by radioligand binding measurements to be ~8,000 per 
cell (Jenness, Burkholder et al. 1986).  
To measure expression of Sst2 and Gpa1, we performed quantitative immunoblotting of 
whole-cell extracts.  Cells in mid-log phase were harvested, lysed directly in SDS-PAGE 
sample buffer, and resolved by gel electrophoresis and immunoblotting.  Absolute 
expression levels were determined using standards in which known quantities of purified 
recombinant Sst2 or Gpa1 were mixed with lysates from sst2 or gpa1 mutants, 
respectively.  These data reveal that each cell contains ~ 8,000 copies of Gpa1, equal to the 
26
number of receptors, and ~ 2,000 copies of Sst2 (Fig. 2.1A, Table I).
Since the genes that encode GPA1 and SST2 are induced upon pheromone stimulation, 
we also monitored the expression levels of the encoded proteins over the course of a 2 h 
treatment with -factor.  The relative expression of each protein was again determined by 
immunoblotting (Fig. 2.1B).  These data reveal that Sst2 is induced 2.5-fold after 1 h of 
treatment, and then declines slightly during the remainder of the experiment.  Gpa1 
expression is increased by ~50% and remains elevated even after 2 h.  Ste4 expression is not 
altered, although it does undergo a mobility shift as a result of pheromone-dependent 
phosphorylation (Cole and Reed 1991).  These results are summarized in Table I.
Protein Number Source
Receptor (Ste2) 8,000 (Jenness, Burkholder et al. 1986)
G (Gpa1) 8,000 (12,000) Experimental measurement.
G (Ste4) 8,000 Inferred
G (Ste18) 8,000 Inferred
RGS (Sst2) 2,000 (5,000) Experimental measurement
Table I.  Protein expression values are number/cell.  Numbers in parenthesis are maximum values (after 
pheromone-treatment).
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FIG. 2.1.  Time course of RGS and G protein induction after pheromone stimulation.
(A)  To determine the levels of expression of Sst2 and Gpa1 in yeast, known amounts of purified 
recombinant protein ("standard") were mixed with whole-cell lysates from gpa1 and sst2 mutants 
respectively, resolved by 7.5% SDS-PAGE and immunoblotting, and probed with anti-Gpa1 and anti-Sst2 
antibodies as indicated ("IB").  To estimate the relative protein expression the bands were analyzed by 
densitometric scanning.  Calculated expression levels of endogenous Gpa1 and Sst2, with ("+") and 
without ("-") 1 h treatment with 3 µM -factor, are summarized in Table I.  Note that a portion of 
endogenous Gpa1 and none of the E. coli-expressed Gpa1 is myristoylated (Myr-Gpa1), as reported 
previously (Stone, Cole et al. 1991; Dohlman, Goldsmith et al. 1993).  (B) Whole cell extracts were 
prepared from wild-type (BY4741) cells transformed with a single copy plasmid (pRS316) containing 
genomic SST2 ("2XSST2") or no insert, and treated with 3 µM -factor for the indicated times.  Samples 
were resolved by 7.5% SDS-PAGE and immunoblotting, and probed using anti-Gpa1, anti-Ste4, or 
anti-Sst2 polyclonal antiserum as indicated  ("IB").  The upper Ste4 band corresponds to the 
phosphorylated form of the protein and is induced by pheromone (Cole and Reed 1991).  The specificity 
of each antibody was confirmed using gene deletion or diploid cells lacking the indicated gene product 
(not shown).  To estimate the difference in protein expression the Sst2 band was analyzed by 
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densitometric scanning (bottom panel).  The data shown are representative of two independent 
experiments.  
We also examined whether perturbations in the expression of each signaling component 
would alter the pheromone response.  Cells expressing normal amounts of Sst2, receptor 
and all three G protein subunits were compared to cells engineered to express double (“2X”) 
the normal amount of each component (Figs. 2.2 and 2.3).  For this purpose, genomic 
copies of STE2, GPA1, SST2, STE4, and STE18 were subcloned into a centromere-based 
shuttle vector and transformed into wild-type cells.  An sst2 mutant was also tested, since 
that would provide information about pathway activation in the absence of feedback 
inhibition and GTPase acceleration.  Other deletions lead to permanent activation of the 
pathway (gpa1) or a complete loss of responsiveness (ste2, ste4, ste18) and were not 
tested (Dohlman and Thorner 2001).  Changes in protein expression were confirmed in each 
case by immunoblotting using polyclonal antibodies against Ste2, Gpa1, Ste4, and Sst2.  
Alterations in pheromone sensitivity were measured using a reporter transcription assay 
comprised of a pheromone-responsive promoter (from FUS1) fused to lacZ (-galactosidase).
This particular assay was chosen because it is sensitive, quantitative, and highly specific for 
Gpa1 signaling (Hoffman, Garrison et al. 2002).  We chose not to use fluorescence-based 
measures of G protein dissociation because they require modifications or fusions that might 
alter G protein stability, localization, or activity (Janetopoulos, Jin et al. 2001).
As shown in Fig. 2.2, two-fold overexpression of the receptor, G protein -subunit, and 
G subunit had no effect on pheromone sensitivity.  In contrast, overexpression of G
produced a dramatic increase in activity over the entire range of pheromone concentrations. 
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Basal activity (no pheromone added) was also elevated, so that it was nearly equivalent to 
FIG. 2.2.  Double expression of Ste4 activates 
the mating pathway.  
Pheromone-dependent transcriptional 
induction was measured following transformation 
of wild-type cells with a single copy plasmid 
(pRS316) containing (A) genomic STE2
("2XSTE2"), GPA1 ("2XGPA1"), STE18
("2XSTE18") or (B) STE4 ("2XSTE4"), and 
co-transformation with a pheromone-responsive 
FUS1 promoter-lacZ reporter 
(pRS423-FUS1-lacZ).  Cells were then treated 
with the indicated concentrations of -factor for 
90 min, and the resulting -galactosidase 
activity was measured spectrofluorimetrically.  
Activity is given in arbitrary units.  To avoid 
selection for spontaneous sterile mutations the 
STE4-overexpressing cells were co-transformed 
with GPA1 under control of the GAL1/10
promoter (pRS315-GAL-GPA1), and 
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maintained in galactose medium until the final inoculation into dextrose medium prior to performing the 
experiment.  Insets, to confirm double expression of each gene product, the same cells were lysed and 
analyzed by immunoblotting with anti-Ste2, anti-Gpa1, anti-Ste4, or anti-Ste18 polyclonal antibodies.  
The data shown are representative of at least two independent experiments performed in triplicate.  (C)
Predicted pheromone-dependent transcriptional induction for the WT (solid line) and 2xSTE4 (dot-dashed 
line) strains.  The model accurately captures the increased activity over the entire range of pheromone 
concentrations observed above for doubled expression of STE4. The response is scaled relative to the 
maximum response in wild-type cells (response = 1).  Details of the model and the parameter values used 
to produce these and subsequent results are given in the “Experimental Procedures.” The model was 
constructed by Dr. Necmettin Yildrim and Dr. Tim Elston.
wild-type cells treated with a maximally effective dose of pheromone.  Thus 2-fold 
overexpression of G is sufficient to fully activate the pathway.  This is consistent with the 
model that G is necessary and sufficient for pathway activation, and that G is the limiting 
component of the G heterodimer complex (Whiteway, Hougan et al. 1990).  Two-fold 
overexpression of SST2 led to a reduction in the maximum response by 27% (Fig. 2.3A).  
Deletion of SST2 did not alter the maximum response, but rather resulted in a 100-fold 
decrease in the concentration of -factor necessary to achieve 50% of the maximum agonist 
response (EC50) (Fig. 2.3A).  These data reveal that, while loss of SST2 affects potency (a 
decrease in EC50), overexpression of SST2 causes a decrease in efficacy, or maximum 
response.  
Having established for each component the expression levels and functional 
consequences of altered expression (Figs. 2.2 and 2.3), we devised a simple mathematical 
model to describe pathway activation and inactivation with a set of two coupled ordinary 
differential equations (i.e. containing only one independent variable, usually time).  A 
detailed description of the modeling is provided under "Experimental Procedures" and is
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FIG. 2.3.  Double expression of Sst2 
attenuates the response to pheromone.
(A) Pheromone-dependent 
transcriptional induction was measured 
following transformation of wild-type 
cells with a single copy plasmid (pRS316) 
containing genomic SST2 ("2XSST2"), 
transformation of wild-type cells with the 
same plasmid containing no insert ("WT"), 
or transformation of an sst2 mutant with 
plasmid containing no insert ("sst2").  
The same cells were co-transformed with 
a pheromone-responsive FUS1
promoter-lacZ reporter.  Cells were then 
treated with the indicated concentrations 
of -factor for 90 min, and the resulting 
-galactosidase activity was measured 
spectrofluorimetrically.  Inset, to 
confirm expression of Sst2, the same cells 
were lysed and analyzed by 
immunoblotting with anti-Sst2 polyclonal 
antibodies.  The data shown are 
representative of at least two independent 
experiments performed in triplicate.  (B) Predicted pheromone-dependent transcriptional induction for the 
three strains shown in panel A.  The model captures the decrease in EC50 seen in the sst2 strain (dashed 
line) relative to the wild-type strain (solid line). However, it cannot fully account for the decrease in the 
maximal response seen in the 2xSST2 strain (dot-dashed line) without also producing an artificial increase 
in the maximal response of the sst2 strain.  The response is scaled relative to the maximum response in 
wild-type cells (response = 1). The model was constructed by Dr. Necmettin Yildrim and Dr. Tim 
Elston.
shown schematically in Fig. 2.4A.  The model assumes that G  is produced in excess of G
(but G is limiting so final expression levels are equal) and that receptor and G are present 
in equal amounts and are always associated, so that individually changing the concentration 
level of G, receptor and G does not affect the model.  These assumptions are consistent 
with data shown in Fig. 2.2 for the double expression of Ste18, Ste2, and Gpa1.  Thus the 
model only considers G and the RGS protein.  Free G activates the intracellular signal 
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leading to new gene expression, and the RGS protein has a negative effect on the pathway by 
increasing the rate at which G recombines with GGDP. The model produces several 
predictions that can be compared with the experimental results presented above.  Typical 
time series generated by the model for release of free Ste4/Ste18 ([G]) and the expression 
of Sst2 ([RGS]) are shown in Fig. 2.4B.  The model predicts a sharp initial increase of free 
G in response to pheromone, followed by a slow decrease as the Sst2 concentration begins 
to rise.  The initial slow rise in Sst2 expression is in good qualitative agreement with data 
shown in Fig. 2.1B for the wild-type (“WT”) strain.  However, the model cannot reproduce 
the slow decline in Sst2 levels seen at later times (see below).  The model can be used to 
derive an expression for response R of the signaling pathway as a function of pheromone 
concentration [L].  The general form of this expression is 
[ ]
[ ]min max
R C R L
R
C L
+= + (1) 
where Rmin is the response in the absence of pheromone and  Rmax is the maximum response.  
Explicit expressions for Rmin, Rmax and C in terms of [L], steady-state RGS concentration and 
the model parameters are provided in the “Experimental Procedures.” As can be seen from 
Fig. 2C, the model correctly captures the increased response over the entire range of 
pheromone concentration where G is overexpressed (Fig. 2.2B).  The model also captures 
the dependence of the EC50 on Sst2 (compare Figs. 2.3A and 2.3B).
There are two qualitative features of the data that are not captured by the model.  First,
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FIG. 2.4. Pathway regulation by RGS 
and G proteins.
(A) Upon binding of the ligand 
(“L”) -factor (“F”) to its receptor  
(“R”, Ste2), the G protein  subunit 
(Gpa1) releases GDP, binds to GTP, 
and liberates the G protein  subunits 
(Ste4/Ste18).  Sustained signaling 
requires activation of multiple effectors 
(not shown) by the dissociated G 
components.  These effectors activate 
a pathway (dotted line) leading to 
transcription of several genes including 
the RGS protein (Sst2).  GTP 
hydrolysis is accelerated by the RGS 
protein, and this leads to subunit 
reassociation and pathway inactivation.   
The model assumes that GTP 
hydrolysis is the rate-limiting step of 
subunit reassembly.  A potential 
positive feedback loop leading to Sst2 
degradation is indicated by a darker 
line.  (B) In the computer simulation 
the concentration of free G (solid line) 
increases rapidly after addition of pheromone (at time = 0).  The concentration of RGS (dashed line) 
responds slowly and eventually inactivates the pathway leading to a reduction in free G. The 
experimentally observed induction of Sst2 (from Fig. 1B) is also shown (solid circles).  The details of the 
model and parameter values used in the computer simulation are presented in the “Experimental 
Procedures.” The model was constructed by Dr. Necmettin Yildrim and Dr. Tim Elston.
deletion of SST2 has no affect on the maximum response, whereas 2-fold overexpression of 
SST2 produces a 27% reduction in the maximum response (Fig. 2.3A).  The model cannot 
simultaneously account for both observations.  Second, in the strain containing two copies 
of SST2 the expression level is relatively constant at early times following pheromone 
addition, and then increases sharply between 60 and 105 min (Fig. 2.1B).  The initial slow
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FIG. 2.5.  Double expression of Sst2 eliminates the response in a subpopulation of cells.
Pheromone-dependent transcriptional induction was measured following transformation of wild-type 
cells with a single copy plasmid (pRS316) containing genomic SST2 ("2XSST2") or transformation of 
wild-type cells with the same plasmid containing no insert ("WT").  The same cells were co-transformed 
with a pheromone-responsive FUS1 promoter-GFP reporter.  Cells were then treated with -factor for 90 
min, and the resulting fluorescence in each cell was monitored by cell sorting.  Pathway activation results 
in an increase in cells with >100 fluorescence units of activity.  The peak below 10 units is also seen in 
cells lacking the reporter, and likely represents auto-fluorescence noise.
increase in Sst2 expression followed by a rapid increase in expression is not consistent with 
the model.
To investigate the discrepancies between the experimental results and the model 
predictions, the transcription assay was repeated using the green fluorescent protein (GFP) 
instead of -galactosidase as a reporter.  The use of GFP allows the activity of individual 
cells to be measured by flow cytometry (Poritz, Malmstrom et al. 2001; Siekhaus and Drubin 
2003).  Wild-type cells containing a single copy plasmid containing no insert ("WT") or a 
genomic SST2 clone ("2XSST2") were treated with -factor for 90 min.  As shown in Fig. 
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2.5 there is in all cells a single peak of low-intensity fluorescence (peak activity between 10 
and 100 units) in the absence of pheromone, which upon pheromone treatment is diminished 
and replaced by a second peak of higher intensity (peak activity between 100 and 1000 units) 
(Poritz, Malmstrom et al. 2001).  Whereas the shift from low intensity to high intensity is 
nearly complete under normal conditions, a prominent low intensity peak persists in cells that 
overexpress SST2.  These data indicate that the reduced maximum response seen in Fig. 
2.3A is most likely due to a subpopulation of cells that is completely unresponsive.  
Whereas the response to pheromone is normally graded, it can become binary (all-or-none) 
when Sst2 is overexpressed. 
One way that binary responses can occur is through positive feedback regulation (Tyson, 
Chen et al. 2003). Thus we considered a phenomenological model in which pheromone 
promotes a second feedback loop leading to faster Sst2 degradation (see “Experimental 
Procedures” for details of the model).  The model makes the reasonable assumption that 
alterations in the expression of Sst2 occur more slowly than alterations in the activation state 
of the G protein.  Stated differently, the activation state of the G protein adjusts rapidly to 
the slow variation in Sst2 concentration, and is therefore assumed to be in equilibrium.  This 
assumption allows the state of the system to be determined by Sst2 expression levels alone.  
The model for the 2xSST2 strain is shown schematically in Fig. 2.6A.  The rates of Sst2 
production (solid lines) and degradation (dashed lines) are shown as a function of Sst2 
expression.  The two straight lines represent Sst2 production and degradation rates in the 
absence of pheromone.  In this case production is independent of Sst2 expression while
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FIG. 2.6.  Modeling Sst2 inhibition.
(A) Sst2 production rates (solid lines) and 
degradation rates (dashed lines) as a function of Sst2 
concentration.  The two straight lines are the constitutive 
rates.  Where the lines intersect represents a steady state 
(“constitutive steady state”).  The upper curves are the 
pheromone-induced rates.  At moderate Sst2 levels, 
pheromone-induced expression and degradation are 
enhanced and almost equal causing the system to respond 
slowly.  At high Sst2 levels the pathway is inhibited, so 
transcription and degradation of Sst2 are also diminished 
and eventually reach a new steady state (“induced steady 
state”).  (B) Time courses generated by the model 
depicted in panel A.  The slow response of the system at 
early times is clearly visible.  The solid line is the result 
from the model in the absence of stochastic effects.  The 
dot-dashed line is the average result for the stochastic 
model.  Details of the model and parameter values are 
given in the "Experimental Procedures."  (C) A 
histogram of the data generated by the stochastic model 
of Sst2 inhibition.  The dashed vertical line indicates the 
time at which samples were collected, and clearly shows 
a binary response that is transient and disappears at later 
times.  Values for Sst2 concentration and times are 
arbitrary. All of these models were constructed by Dr. 
Necmettin Yildrim and Dr. Tim Elston.
degradation is proportional to Sst2 expression.  Where the lines intersect production and 
degradation rates are equal (“constitutive steady state”).  The two curved lines represent 
Sst2 production and degradation rates in the presence of pheromone.  At low Sst2 
expression, the induced production rate exceeds the constitutive production rate.  At higher 
Sst2 expression the pathway is inhibited, SST2 transcription in diminished and the induced 
37
production rate approaches the constitutive rate.  The degradation rate also has a non-linear 
dependence on Sst2 expression.  At low Sst2 expression, pheromone promotes Sst2 
degradation as part of a positive feedback mechanism.  At higher Sst2 expression the 
pathway is inhibited, Sst2 degradation is diminished and the induced degradation rate 
approaches the constitutive rate.  Where the lines intersect production and degradation rates 
are equal (“induced steady state”).
Using the revised model we can understand the slow initial induction of Sst2 seen for 
the 2xSST2 strain (see Fig. 2.1B).  Initially the system is in steady state ([Sst2] ~ 0.4).  
After exposing the cells to -factor, the production rate exceeds the degradation rate slightly, 
and the Sst2 levels slowly increase.  As Sst2 expression increases the degradation rate falls 
more rapidly than the production rate, and eventually the level of Sst2 begins to rise until it 
reaches a new steady state ([Sst2] ~ 1.2).  The dot-dashed line in Fig. 2.6B is a time series 
produced by this model, and shows good qualitative agreement with the experimental results 
in Fig. 2.1B.  For simulation of the 2xSST2 strain, the constitutive and pheromone-induced 
production rates were double that of the wild-type strain.
In the model described above, even for the 2xSST2 strain, there is only one steady state.  
To test if this model can reproduce the binary response seen in the single cell transcription 
assay shown in Fig. 5 we added a stochastic term to the model to account for random 
fluctuations in protein concentrations levels.  We then performed 10,000 simulations of the 
random model and averaged the results to yield the mean time course indicated by the solid 
line in Fig. 2.6B.  Fig. 2.6C is a histogram of the modeled Sst2 concentrations for each
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FIG. 2.7  Pheromone stimulation promotes the 
degradation of Sst2.
An sst2 mutant strain transformed with (A)
a single copy plasmid (pRS315-ADH) containing 
SST2 under the control of a constitutive promoter 
(from ADH1), or (B) wild-type cells expressing 
genomic SST2 and the native promoter (pRS315) 
were treated with 3 µM -factor for 60 min, and 
then treated with the protein synthesis inhibitor 
cycloheximide (CHX) for the indicated times.  
Cell extracts were analyzed by immunoblotting 
with anti-Sst2 antibodies as described in Fig. 1.  
To estimate the difference in protein half-life the 
intensity of each band was analyzed by 
densitometric scanning.  The data are 
representative of one (panel A) or two (panel B) 
independent experiments.
simulation at single time points indicated by the vertical line at time ~ 22 (Fig. 2.6B).  The 
results presented in Fig. 2.6C shows a clear binary response similar to tha t observed for the 
2xSST2 strain (Fig. 2.5).
Taken together, the revised model requires the existence of a positive feedback 
mechanism leading to pheromone-dependent loss of Sst2.   Thus we investigated whether 
pheromone treatment does in fact promote the degradation of Sst2.  After 1 h of growth in 
the absence or presence of pheromone the cells were treated with cycloheximide to block 
new protein synthesis.  Steady state levels of Sst2 remaining were then monitored by 
immunoblotting.  As shown in Fig. 2.7, Sst2 abundance declined more quickly when
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FIG. 2.8 
Pheromone 
promotes the 
ubiquitination of 
Sst2.  
(A) Wild-type 
cells were 
transformed with 
pRS316-ADH-SST2-
myc, and treated with 
3 µM -factor for the 
indicated times.  
Whole cell lysates 
were then prepared 
and resolved by 7.5% 
SDS-PAGE and 
immunoblotting.  
Monoclonal anti-Myc 
antibodies detect the 
Myc-epitope tagged 
Sst2-myc ("Sst2") 
and a broad high 
molecular weight 
species corresponding 
to a likely 
ubiquitinated form of 
Sst2 ("Ubi-Sst2") that 
accumulates over 
time.  (B) To 
confirm that the 
high-molecular weight species is in fact Sst2, wild-type cells were transformed with the Myc-tagged form of 
Sst2 and probed with anti-Myc monoclonal antibodies.  The high molecular weight species is recognized by 
the anti-Myc antibody, accumulates with pheromone treatment, and is absent in the control cells transformed 
with an empty vector or another Myc-tagged protein (Rgs2) (left panel).  The Sst2 species detected with the 
Myc antibodies was also detected using the anti-Sst2 antibodies (right panel).  (C) To confirm 
ubiquitination of Sst2 the same cells were immunoprecipitated with anti-Myc antibodies ("IP"), resolved by 
7.5 % SDS-PAGE and immunoblotting, and probed with anti-ubiquitin antibodies ("IB").  Data are 
representative of at least two independent experiments.
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pretreated with pheromone.  A similar pattern of degradation was observed when SST2 was 
expressed from a constitutive promoter (Fig. 2.7A) or the native promoter (Fig. 2.7B).  
These data indicate that pheromone stimulates the degradation of Sst2, as predicted by the 
model.
We then investigated whether pheromone-dependent Sst2 degradation results from 
ubiquitination, a modification that has been reported for some mammalian RGS proteins 
(Kim, Arnould et al. 1999; Davydov and Varshavsky 2000).  Ubiquitination is the formation 
of an isopeptide bond between the ubiquitin polypeptide and Lys side chains of the target
protein (Pickart 2001).  Ubiquitin is itself ubiquitinated, resulting in the formation of 
poly-ubiquitin chains.  The poly-ubiquitinated protein is usually then captured and degraded 
by a large protease complex, the 26S proteasome (Voges, Zwickl et al. 1999).  To determine 
if Sst2 is ubiquitinated we analyzed the expression of a Myc-epitope tagged version of the 
protein.  As shown in Fig. 2.8A, long exposures of Sst2 -myc immunoblots revealed a very 
high-molecular weight immunoreactive band, suggesting that the protein is indeed 
poly-ubiquitinated.  This high molecular weight species is barely visible in the untreated 
cells, but accumulates with time and becomes fully modified after 60 min of pheromone 
treatment.  To confirm that the high molecular weight band is Sst2 we demonstrated that it 
is recognized by anti-Sst2 as well as anti-Myc antibodies (Fig. 2.8B).  As an additional 
control we constructed a Myc-tagged version of a second RGS protein in yeast, Rgs2.  Rgs2 
regulates Gpa2 specifically, having no effect on the Gpa1-mediated pheromone response 
(Versele, de Winde et al. 1999).  As shown in Fig. 2.8B, Rgs2 does not exhibit any change
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FIG. 2.9. Ubiquitination of Sst2 
promotes degradation.
(A) Wild-type strains or isogenic 
mutant strains lacking the indicated 
gene were transformed with 
pAD4M-SST2, and treated with 3 µM 
-factor for 60 min.  Cell extracts 
were analyzed by immunoblotting 
with anti-Sst2 antibodies.  Of the 
strains tested, only ubc2 mutants 
exhibit diminished ubiquitination of 
Sst2.  This result was from Dr. Yuqi 
Wang. (B) To determine if diminished 
ubiquitination results in diminished 
degradation, wild-type and ubc2
cells were transformed with 
pRS316-ADH-SST2-myc.  Cells 
were treated with 3 µM -factor and 
cycloheximide as indicated.  Cell 
extracts were then resolved by 
SDS-PAGE and immunoblotting with 
anti-Myc antibodies to detect Sst2 
remaining.  Data are representative of 
at least two independent experiments.
in mobility, either in the absence or presence of pheromone.  To confirm that the appearance 
of a high molecular weight form of Sst2 is due to ubiquitination, the protein was 
immunoprecipitated with anti-Myc antibodies and analyzed by immunoblotting with 
anti- ubiquitin antibodies.  This enrichment scheme again yielded a high-molecular weight 
band recognized by both anti-ubiquitin and anti-Myc antibodies (Fig. 2.8C).
The data presented above indicate that pheromone promotes the ubiquitination and 
degradation of Sst2.  To determine whether ubiquitination of Sst2 leads to degradation, we 
searched for mutants that diminish Sst2 ubiquitination and investigated their effects on Sst2 
42
turnover.  Ubiquitination typically requires three distinct enzymatic activities: a 
ubiquitin-activating enzyme (E1), a ubiquitin-conjugating enzyme (E2), and a 
ubiquitin-ligase (E3).  For our experiments we tested strains lacking E2 ubiquitin 
conjugating enzymes, since most E2-encoding enzymes are not essential and their identity is 
more clearly defined than the E3 enzymes.  All available E2-deficient deletion mutants were 
treated with pheromone for 1h, and then analyzed by immunoblotting with anti-Sst2 
antibodies.  As shown in Fig. 2.9A, Sst2 ubiquitination is diminished in the E2 mutant 
ubc2, but is preserved in all the other mutant and wild-type strains tested.
We then compared the turnover rate of Sst2 in ubc2 mutant and wild-type cells, both in 
the absence and presence of pheromone.  Cells in mid-log phase were treated with 
cycloheximide to block new protein synthesis, and analyzed by immunoblotting with 
anti- Myc antibodies.  As shown in Fig. 2.9B the overall level of Sst2 dropped rapidly when 
translation was blocked in wild-type cells, while the half-life was extended dramatically in 
the ubc2 mutant.  We conclude from these results that Sst2 degradation is slowed when it 
is no longer ubiquitinated.  Taken together, our findings indicate that pheromone promotes 
not only the transcription of SST2, but also the ubiquitination and subsequent degradation of 
the protein.  Together these mechanisms could account for the transient expression of the 
protein following pheromone challenge.
Discussion
Biologists have traditionally described the cellular functions of proteins in qualitative 
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terms, with models based largely on intuition.  Such models typically ignored temporal 
aspects of protein activity, and therefore failed to predict behavior resulting from changes in 
protein expression and turnover.  Moreover, while cellular metabolic or signaling pathways 
were once described as linear and unidirectional they are now recognized to consist of 
complex networks subject to positive and negative feedback regulation.  As our 
understanding of these pathways becomes more sophisticated, however, it has become 
possible to devise models that can account for their complex behaviors, and are therefore 
more accurate, comprehensive and quantitative.  Our ability to identify genes, manipulate 
their expression, and quantify their function has also improved to the point where 
computation models can be reasonably tested experimentally.
Here we have devised a quantitative model that considers the activation, desensitization, 
and resensitization steps following pheromone stimulation in yeast.  This approach has 
allowed us to demonstrate the importance of negative feedback inhibition through induction 
of RGS expression (desensitization), and also prompted our discovery of a positive feedback 
loop leading to RGS ubiquitination and degradation (resensitization).  Only by taking into 
account this second feedback loop were we able to adequately explain the available 
functional data.
The existence of both positive and negative controls on RGS protein expression, acting 
in sequence, could serve as a timing mechanism to allow multiple rounds of pathway 
activation.  If G protein activation occurred without RGS induction the system would reach 
a stable and non-productive “on” state.  Conversely, RGS degradation may be required to 
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eventually restore pheromone responsiveness in haploid cells, thereby increasing the prospect 
of a second chance at successful conjugation.
Sst2 joins a small but growing list of signaling proteins that undergo ubiquitination.  In 
the pheromone response pathway, receptors (Hicke and Riezman 1996; Hicke, Zanolari et al. 
1998; Roth, Sullivan et al. 1998), the G subunit (Madura and Varshavsky 1994; Marotti, 
Newitt et al. 2002), and the effector kinase Ste7 (Wang and Dohlman 2002; Wang, Ge et al. 
2003) are known substrates for ubiquitination.  Ubiquitination of Ste7 is dependent on 
prolonged pheromone stimulation, and once ubiquitinated it is rapidly degraded by the 
proteasome (Wang and Dohlman 2002; Wang, Ge et al. 2003).  Ubiquitination of the 
receptor is also accelerated by pheromone.  However this situation is unusual in that the 
receptor is mono-ubiquitinated rather than poly-ubiquitinated; and ubiquitination in this case 
serves as a signal for endocytosis and delivery to the vacuole instead of the proteasome 
(Hicke and Riezman 1996; Hicke, Zanolari et al. 1998; Roth, Sullivan et al. 1998).  
Ubiquitination of the G protein is not regulated by pheromone, but is noteworthy because it 
was the first ubiquitination site to be directly mapped by mass spectrometry (Marotti, Newitt 
et al. 2002).
Biologist and applied mathematicians have long used similar methods to describe 
input-output relationships of complex systems.  The dose-response profiles so familiar to 
biologists are equally well known to theorists, who refer to them as one-parameter bifucation 
diagrams (Tyson, Chen et al. 2003).  Dose-response profiles are used by pharmacologists 
and physiologists to predict the response of a cell to a specific dose of drug or hormone.  
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Such profiles are also useful to theorists because they summarize the general, qualitative 
properties of solutions of a set of nonlinear differential equations.  However, because 
theorists are not constrained by the same technical and ethical considerations that preclude 
certain biological experiments they may be able to describe or interpret cellular behavior in 
ways that experimentalists cannot, and therefore have the potential to greatly enrich our 
understanding of biological systems.  An example of this potential was realized here, in our 
ability to devise a model of response regulation by Sst2.  While the model did not explicitly 
account for every biochemical step in the pathway, it was consistent with the known biology 
of G protein signaling.  An advantage of using this simple model was that it allowed us to 
make several predictions that could be compared with experimental data.  In particular, we 
found that the model could not simultaneously account for the behavior of the 2xSST2 strain, 
the sst2 mutant, and the wild-type strain at saturating pheromone levels.  The model could 
also not reproduce the slow induction of Sst2 expression observed for the 2xSST2 strain. The 
inconsistencies prompted further experiments, which in turn led to a revised model.
In summary, our analysis accounts for three key aspects of G protein-mediated signaling.  
The signal initiation step, already well established, requires receptor-catalyzed guanine 
nucleotide exchange.  The second step consists of a negative feedback loop, by which 
pheromone promotes RGS expression and G protein inactivation.  RGS proteins were 
already well known to inhibit signaling, but the contribution of transcriptional induction had 
not previously been demonstrated.  The third step was previously unknown, and invokes a 
positive feedback mechanism through induction of RGS protein ubiquitination and 
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degradation.  These findings illustrate how computational modeling, which is not by itself 
hypothesis-driven, can generate novel hypothesis about protein function that can be tested 
experimentally. 
Having described the activity of the early steps in the pheromone signaling pathway, our 
present goal is to model activation of downstream effectors and eventually create computer 
simulations of the entire pathway.  This should be feasible, given that there are relatively 
few components and their activities are well understood.  Such studies should provide new 
insights about how cells communicate and respond to external stimuli, and how those 
responses change over time.  The combination of experimental and computational 
approaches employed here could also be applied to other signaling pathways and other 
organisms, and promises to improve our understanding of how cellular changes in disease 
states can be predicted and managed.
Experimental Procedures
Strains and plasmids.
Standard methods for the growth, maintenance, and transformation of yeast and bacteria, 
and for the manipulation of DNA, were used throughout (Ausubel, Brent et al. 1987).  The 
yeast Saccharomyces cerevisiae strains used in this study are BY4741 (MATa leu2 met15
ura3) or BY4741-derived deletion mutants lacking sst2, ubr1, ubc2/rad6, ubc4, ubc5, 
ubc7/qri8, ubc8, ubc10/pex4, ubc11, ubc12, and ubc13 (Research Genetics, Huntsville, AL).  
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UBC- related gene deletion mutants not tested were ubc1 (inviable), ubc3/cdc34 (inviable), 
ubc6 (unavailable), and ubc9 (required for SUMOylation rather than ubiquitination).
Expression plasmids used in this study are those containing STE2, GPA1, STE4, STE18, 
and SST2.  Each gene was amplified using flanking PCR primers that anneal 600 bp upstream 
or 600 bp downstream of the open reading frame.  The PCR products were then subcloned by 
digestion with BamHI and either Kpn1 (SST2, STE4) or XhoI (STE2, GPA1, STE18) 
(restriction site encoded by the PCR primers) and ligation to pRS316 (Sikorski and Hieter 
1989).  Other plasmids described previously are SST2-myc (Dohlman, Song et al. 1996)
expressed in pRS316-ADH (Song, Hirschman et al. 1996) (plasmid pRS316-ADH-SST2-myc) 
and FUS1-GFP reporter (plasmid pDS30, from Daria Siekhaus, University of California 
Berkeley) (Siekhaus and Drubin 2003).  Methods for purification of Sst2 (Kallal and Fishel 
2000) and Gpa1 (Apanovitch, Slep et al. 1998) were described previously.
Signaling, expression, ubiquitination and degradation assays.
The pheromone-dependent transcription assays using the -galactosidase (Hoffman, 
Garrison et al. 2002) and green fluorescent protein (Poritz, Malmstrom et al. 2001) reporters 
have been described previously.  For immunoblot detection, cell growth was stopped by the 
addition of 10 mM NaN3 and transfer to an ice bath.  To monitor the degradation of Sst2 over 
time, mid-log cell cultures were treated with cycloheximide (10 µg/ml in 0.1% ethanol, final 
concentrations) for up to 120 min before harvesting.  Cells were washed and resuspended 
directly in boiling SDS-PAGE sample buffer (62.5 mM Tris-HCl pH 6.8, 10% glycerol, 2% 
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SDS, 1% 2-mercaptoethanol, 0.0005% bromophenol blue) for 10 min, subjected to glass bead 
homogenization, and clarified by microcentrifugation.  Following SDS-polyacrylamide gel 
electrophoresis and transfer to nitrocellulose, the membrane was probed with antibodies to 
Ste2 at 1:2,000 (from James Konopka, State Univ. of New York), Gpa1 at 1:1,000 (Dohlman, 
Goldsmith et al. 1993), Ste4 at 1:2,000 (from Duane Jenness, Univ. of Massachusetts), Ste18 at 
1:100 (yN-16, Santa Cruz), Sst2 at 1:2,000 (Dohlman, Song et al. 1996), Myc (9E10) at 
1:1,000 (Evan, Lewis et al. 1985), or ubiquitin at 1:100 (Sigma-Aldrich).  Immunoreactive 
species were visualized by enhanced chemiluminescence detection (Pierce) of horse radish 
peroxidase-conjugated anti-rabbit IgG (BioRad) or anti-goat IgG (Santa Cruz).  Specificity of 
antibody detection was established using gene deletion mutants, diploid cells (which do not 
express the receptor, G protein, or RGS protein) or non-Myc-tagged SST2 as negative controls.
Ubiquitinated Sst2 was enriched by immunoprecipitation prior to immunoblotting.  Cells 
were grown to mid-log phase and either treated with 3 µM -factor or with water for 1 h.  
Approximately 100 ml of cells at A600nm = 1 were harvested and lysed at 4°C in 600 µl of lysis 
buffer (25 mM Tris-HCl pH 7.4, 200 mM NaCl, 15 mM EGTA, 15 mM MgCl2, 0.1% 
Triton-X100, 10% glycerol, 1 mM NaN3, 1 mM dithiothreitol, 10 mM N-ethylmaleimide, 5 
mM phenylmethyl sulfonyl fluoride, 1 µg/ml pepstatin, and 1 µg/ml leupeptin) with the use of 
acid-washed glass beads and 30 sec pulses of vortexing, repeated six times.  Samples were 
centrifuged for 10 min at 6,500 g, and the resulting supernatant was removed and diluted to a 
final volume of 1 ml with wash buffer (the same as lysis buffer except no glycerol).  Lysates 
were incubated with 40 µl of 9E10 anti-Myc antibodies for 90 min on ice.  After clarification 
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with 10 min high speed microcentrifugation at 4°C, protein-antibody complexes were 
precipitated for 1 h at 4°C with 40 µl of a 50% slurry of protein G-Sepharose 
(Amersham-Pharmacia) equilibrated in wash buffer.  Immunoprecipitates were collected by 
centrifugation at 2,000 g for 30 sec, and pellets were washed with wash buffer before final 
resuspension in 50 µl of 2 × SDS PAGE sample buffer. 
Deterministic Modeling of Regulation by Sst2
To help elucidate the mechanism by which Sst2 regulates the pheromone response 
pathway, we constructed a simple mathematical model of the system.  The variables in the 
model are the time dependent concentrations of Ste4/Ste18 ([G]) and Sst2 ([RGS]).  We 
assume that the total concentration of G, [G]T = [G] + [GGDP] is constant in time.  
We also assume that the rate-limiting step in the reformation of GGDP after exposure to 
pheromone is the hydrolysis of GTP.  Once hydrolysis occurs, GGDP and G rapidly 
combine to produce GGDP.  The dynamics of [G] is governed by the ordinary 
differential equation (ODE)
( ) [ ]( ) [ ]1 1 2 3[ ] [ ] [ ] [ ]GTP GTPTd G k f k G G k G k RGS Gdt    = +    .       (2) 
The first term on the right-hand side of Eq. (2) represents the rate at which free G  is 
liberated from GGDP.  The parameter k1 is the rate constant for the process in the absence 
of pheromone and k1’ is the pheromone-induced rate constant.  The fraction of ligated 
receptors at pheromone concentration [L] is given by f = [L]/(K+[L]), where K is the effective 
dissociation constant for ligand binding.  The second term on the right-hand side of Eq. (2) 
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represents the loss of free G by RGS-independent formation of GGDP.  The reason this 
term does not explicitly depend on [G] is because of our assumption that after exposure to 
pheromone, GTP hydrolysis is the rate-limiting step in the reformation of GGDP.  The 
final term models the acceleration of this process by RGS (negative feedback).  k2 are k3 are 
the corresponding rate constants for these two processes.  By assuming that the total G
concentration, [G]T = [GGDP] + [GGDP]+[GGTP], is constant in time and that [GGDP] 
 0, [GGTP] can be written in terms of [G] as follows, [GGTP] = [G]T - [G]T + [G].  
Making this substitution in Eq. (2) produces
( ) [ ]( ) [ ]( ) [ ] [ ]( )1 1 2 3[ ] [ ] [ ]T T Td G k f k G G k k RGS G G Gdt     = +   +  + (3) 
For the wild-type strain, we assume that [G] = [G]T and for the strain in which G is 
doubly expressed, we assume [G] is present at twice the wild-type level. 
We assume that the RGS concentration evolves according to the following equation
[ ] [ ] [ ]4 5d RGS k k G RGSdt  = +  . (4) 
where k4 is the constitutive rate of RGS production, k5 is the pheromone-induced rate of RGS 
production and   is the degradation rate of RGS.  While Eqs. (3) and (4) lack many 
biological details, it is shown in the “Results” that this simple model provides insight into the 
signaling pathway.  Eqs. (3) and (4) were solved numerically using MatLab.  The 
pheromone-dependent transcriptional induction curves shown in Figs. 2C and 3B were 
produced from the relation R = [G]ss/([G]ss+), where R is the response, [G]ss is the 
steady-state value of [G] and  is the value of [G] at which the response is half its 
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maximum value.  Eq. (3) can be used to write R in terms of [L] and the steady-state RGS 
concentration [RGS]ss.  The result is given by Eq. (1) where Rmin, Rmax and C are defined as 
follows:
1 2 3
min
1 2 3 1 2 3
[ ] - ( )([ ] -[ ] )
( ( )) [ ] - ( )([ ] -[ ] )
T T T
T T T
G k k k RGS G GR
k k k RGS G k k k RGS G G
  
   
+= + + + +
(5) 
'
1 1 2 3
max '
1 1 2 3
[ ] ( ) - ( )([ ] -[ ] )
( [ ] )( )+( )( ([ ] -[ ] ))
T T T
T T T
G k k k k RGS G GR
G k k k k RGS G G
  
    
+ += + + + 
(6) 
1 2 3 1 2 3
'
1 1 2 3
( ( )) [ ] - ( )([ ] -[ ] )
( [ ] )( )+( )( ([ ] -[ ] ))
T T T
T T T
k k k RGS G k k k RGS G GC
G k k k k RGS G G
   
    
+ + + += + + +  .
(7) 
The parameter values used to produce Figs. 2C, 3B and 4 are k1 = 5.25×10-5 min-1, k1’ = 1.75 
min-1, K = 2.0×10-3 mM, [L] = 3×10-3 mM,  [G]T = 2×10-4 mM, k2 = 3.5×10-3 min-1, k3 = 
3,500 min-1mM-1, k4 = 2.5×10-6 mM min-1, k5 = 2.5×10-2 min-1,   = 5×10-2  min-1 and  = 
2.0 mM. 
To simplify the model further, we make the reasonable assumption that changes in free 
G occur on a much shorter time scale than changes in RGS expression.  That is, we 
assume that [G] is in equilibrium with respect to the current RGS expression level.  
Mathematically, this means that the time derivative in Eq. (3) is equal to zero.  Solving the 
resulting equation for [G] and substituting the result into Eq. (4) produces 
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[ ] [ ] ( )
[ ] [ ]
[ ] [ ]
5 1 1
4
1 1 2 3
4 ,
T
nf
k G k f kd RGS
k RGS
dt f k k k k RGS
Sk RGS
K RGS



+
= +  + + +
= + +
(8) 
where S = k5[G]T(k1+fk1’)/k3 , Knf = (fk1’+k1+k2)/k3, and we have made the simplifying 
assumption that [G] = [G]T.  In the above equation, the negative effect of RGS is clear.  
The maximum response in the absence of RGS is S/Knf.  As [RGS] increases, the production 
rate returns to k4.
Stochastic Modeling of Sst2/RGS inhibition
Whereas deterministic models describe the average behavior of a number of individual 
cells, stochastic models describe the diverse behavior of many individual cells. To illustrate 
that pheromone-induced Sst2 degradation through ubiquitination is sufficient to explain the 
experimental results obtained for the 2xSST2 strain, we modified Eq. (8) in the following 
way:
[ ]
[ ] [ ] [ ]( )( )4 1 [ ] Noisenf
d RGS Sk RGS L g RGS
dt K RGS
= +  + ++
(9) 
The function g models the effect of pheromone-induced ubiquitination and increases the 
degradation rate.  We assume that RGS inhibits its own degradation, which would be the 
case if free G initiated the pathway leading to RGS ubiquitination, and take g to have the 
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form
[ ]( ) [ ][ ]max 4 ,RGS
g RGS
g RGS
K RGS
= +
(10)
where gmax is the maximum value of g and KRGS determines where g reaches half its 
maximum value.  Finally, we add a noise term in Eq. (9) to model fluctuations in the 
concentration due to the stochastic nature of chemical reactions.  In general, the strength of 
the noise depends on the biochemical reactions in the signaling pathway (Kepler and Elston 
2001).  However, for simplicity we model this term as Gaussian white noise of strength D.  
Eq. (9) was solved numerically using an Euler method, and 10,000 realizations of the process 
were used to produce the results shown in Figs. 6B and 6C.  The parameter values used in 
these figures are k4 =  0.02, S = 0.36, Knf  = 0.09, KRGS = 0.35, [L] gmax = 0.9,  = 0.2, and 
D = 0.0001.
CHAPTER 3. NEGATIVE FEEDBACK REGULATION OF 
THE YEAST OSMOTIC STRESS PATHWAY
Abstract
A common property of signal transduction systems is that they often act transiently in 
the face of an unchanging initial stimulus. For instance in yeast, the mitogen-activated 
protein (MAP) kinase Hog1 is activated and inactivated within minutes, even when the 
osmotic-stress stimulus is sustained. Here we used a combination of experimental and 
computational analysis to investigate the dynamic behavior of Hog1 activation in vivo. 
Computational modeling  suggested that a negative feedback loop operates upstream in the 
pathway, most likely at the membrane-bound osmosensor Sho1. Experimental analysis 
revealed that Sho1 is phosphorylated by Hog1.  Moreover, Sho1 exists in a homo-oligomeric 
complex, and phosphorylation of Sho1 promotes a transition from the oligomeric to 
monomeric state. Phosphorylation-site mutations diminish the formation of Sho1-oligomers 
and dampen further activation of the Hog1 kinase. These findings reveal a 
phosphorylation-dependent feedback loop leading to diminished Sho1-Sho1 assembly and 
transient cellular responses to an osmotic stress stimulus.
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Introduction
All living organisms can initiate distinct developmental programs depending on the 
presence of specific external cues. In many cases those cues lead to activation of protein 
kinases, which in turn regulate a variety of cellular behaviors including metabolism, gene 
expression, cell division, cell motility, differentiation, and death (Johnson and Lapadat 2002). 
Many such cellular behaviors are regulated by a single MAP kinase, but the response 
depends on discrete changes in the intensity or duration of kinase activity. In one oft-cited 
example, epidermal growth factor causes transient activation of the ERK MAP kinase and 
leads to cell proliferation, while nerve growth factor causes sustained ERK activation and 
results in cell differentiation (CJ. 1995). Moreover, abnormal or inappropriate activation of 
MAP kinase activity can lead to asthma, autoimmune diseases and cancer.
Despite the importance of temporal regulation in signal transduction, the underlying 
mechanisms leading to transient pathway activation are often poorly defined. Most work in 
this regard has focused on feedback inhibition through phosphorylation, as well as pathway 
regulation by protein kinase scaffolds and protein phosphatases (Morrison DK 2003; Martin 
H 2005). Phosphorylation is of special interest because it provides a rapid and reversible
means for the dynamic control of signaling. Thus the activity of any MAP kinase reflects a 
balance of the activating kinases and inactivating phosphatases. 
Previous computational analysis highlighted the role of MAP kinase phosphatases in 
determining the timing and duration of MAP kinase activation (Bhalla, Ram et al. 2002). That 
analysis demonstrated that a MAP kinase-induced increase in MAP kinase phosphatase 
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expression moves the signaling network from a bistable state, in which a brief stimulus results 
in sustained MAP kinase activation, to a monostable state in which the system responds in a 
manner proportional to the stimulus. In yeast, phosphatases have likewise been proposed to 
play a critical role in MAP kinase signaling. For example, activation of the MAP kinase Hog1 
leads to enhanced expression of protein Tyr-phosphatases Ptp2 and Ptp3, but the induction in
this case is rather modest and occurs too slowly to explain the rapid inactivation of Hog1 
(Jacoby, Flanagan et al. 1997; Wurgler-Murphy, Maeda et al. 1997).
To better understand the dynamics of signal regulation we investigated the high 
osmolarity glycerol response pathway in yeast mediated by Hog1 (Hohmann 2002). Hog1 is 
required for cell adaptation to osmotic stress conditions (Brewster, de Valoir et al. 1993), and 
does so through increased production of a compatible solute that serves to equalize cellular 
osmotic pressure with the external environment. The nature of the solute differs in various 
organisms but in yeast it is glycerol. Yeast mutants that cannot produce or retain glycerol show 
diminished viability after an osmotic shock despite strongly enhanced and sustained Hog1 
phosphorylation. On the other hand constitutive, or non-transient, activation of Hog1 leads to 
cell death. Therefore, strict control over the dynamics of Hog1 activation is essential for cell 
survival (Hohmann 2002).
High osmolarity stimulates at least two putative osmosensing proteins in yeast, Sho1 and 
Sln1, that independently activate Hog1. Sln1 is an integral membrane protein homologous to 
bacterial two-component signal transducers. Upon stress stimulation Sln1 activates two 
partially redundant kinases (Ssk2 and Ssk22), which then activate the MAP kinase kinase Pbs2 
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and ultimately Hog1. The second osmosensor Sho1 binds and activates a distinct MAP kinase
kinase kinase Ste11, which then activates Pbs2 and Hog1. Although they are widely referred to 
as osmosensing “receptors,” Sho1 and Sln1 are not likely to serve as receptors in the usual 
sense since they respond to such a wide range of chemically distinct substances. Indeed the 
transmembrane domains of Sho1 are not specifically required to sense changes in osmolarity 
or even to activate the Hog1 pathway (Raitt, Posas et al. 2000). Rather, these osmosensing 
proteins may be activated through a physical stimulus that accompanies cell shrinkage or 
membrane remodeling.
The utility of multiple branches converging on a single MAP kinase is not established, but 
it may help the cell to respond over a wide range of osmolarity changes (Maeda, Takekawa et al. 
1995). Whereas the Sln1 branch responds in a linear fashion up to about 600 mM NaCl, Sho1 
operates in an all-or-none fashion. The Sho1 branch is considered here because activation of 
Hog1 is in this case unusually transient, while activation by Sln1 is more persistent
(Vandenbol, 1989). Moreover, the all-or-none behavior of the Sho1 branch is highly 
characteristic of a system that is subject to feedback regulation.
We began our analysis by first developing simple mathematical models of Hog1 
signaling and its regulation. These models predicted the existence of a desensitization event 
early in the pathway that requires Hog1 kinase activity. Our experimental analysis revealed
that Hog1 phosphorylates Sho1. Moreover, we found that Sho1 exists normally as a 
homo-oligomer, and that phosphorylation leads to loss of Sho1 oligomerization and 
diminished signaling. These events constitute a novel negative feedback loop contributing to 
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the temporal control of Hog1 activation. Further computational analysis indicates that the 
Sho1 signaling cascade is designed for both high sensitivity and transient activation. Given 
the conservation of MAP kinase signaling in all eukaryotes, the mechanisms outlined here are 
likely applicable to other signaling pathways in yeast as well as in animals.
Results
Computational modeling
Our goal here was to identify new mechanisms of desensitization, focusing specifically 
on the osmotic stress-response pathway mediated by Hog1. Initially we compared Hog1 
activation by either the Sln1 branch alone (in a sho1 mutant) or the Sho1 branch alone (in 
an ssk1 mutant). Cells were treated with 0.5 M KCl, resolved by immunoblotting, and 
probed with phospho-p38 antibodies that recognize the phosphorylated and activated form of 
Hog1. In this comparison we found that signaling from the Sho1 branch is more transient 
than the Sln1 branch, as noted previously (Fig. 3.1A) (Vandenbol, 1989). Since our interest 
was in mechanisms of signal inactivation, we restricted our investigations to the Sho1 branch 
of the pathway.
To better guide our analysis we began by constructing a number of simple mathematical 
models of Hog1 activity. This approach requires quantitative information about the 
dose-dependence and duration of pathway activation. Accordingly, Fig. 3.1B shows a 
measured time series for Hog1 phosphorylation in the presence of different concentrations of 
KCl (hereafer “salt”). In this analysis phospho-Hog1 increased rapidly, peaking at 
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Fig. 3.1 Hog1 kinase activity is required for transient pathway activation.
(A) To determine the kinetics of activation by the Ssk1- and Sho1-mediated signaling pathways, 
sho1 or ssk1 mutants respectively were treated with 0.5 M KCl for the times indicated; cell lysates were 
then resolved by 10% SDS-PAGE and immunoblotting (IB) with anti-phospho p38 antibodies, which 
recognize the phosphorylated and activated form of Hog1. (B) To determine the dose-response relationship 
of Sho1 activation, ssk1 cells were treated with different concentrations of KCl and subjected to 
immunoblotting with anti-phospho p38 or anti-Hog1 antibodies (loading control). (C) To determine the 
contribution of Hog1-mediated phosphorylation on its own activity, ssk1 (HOG1) cells or isogenic cells 
bearing a catalytically inactive gene replacement mutant (hog1K42R) were treated with KCl and analyzed 
by immunoblotting. (D) To determine the contribution of Ptp2-mediated dephosphorylation on Hog1 
activation, ssk1 (PTP2) cells, isogenic ptp2 mutants, hog1K42R mutants, or ptp2 hog1K42R double 
mutant cells were treated with KCl and analyzed by immunoblotting. (E) Three models of Hog1 regulation, 
as detailed in the text. (F) Scanning densitometry of data from panel B (symbols) were plotted together 
with simulated data for each of the three models presented in panel E (lines). The densitometry data was 
scanned from two independent experiments and averaged. The models were constructed by Marcelo 
Behar and Dr. Tim Elston.
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approximately 5 min, and was followed by a decrease to basal levels within 30 min. This 
behavior was strongly dose-dependent since 2-fold changes in salt concentration resulted in 
dramatic differences in phospho-Hog1 levels. Moreover, Hog1 appears to regulate its own 
activity, since a catalytically-inactive mutant reached a much higher level of maximum 
phosphorylation, and failed to return to baseline levels even after 60 min of stimulation 
(compare Fig. 3.1C) (Wurgler-Murphy, Maeda et al. 1997). 
We then used the available data to construct our mathematical models of Hog1 
inactivation. Given the striking differences between Hog1 phosphorylation in the absence 
and presence of kinase activity, all three models invoked some Hog1-dependent 
phosphorylation event. Each model was then evaluated for its ability to reproduce our 
experimental data and for consistency with previously published experimental observations. 
The first model invokes Hog1-mediated activation of a downstream negative regulator. The 
model does not dictate a specific substrate, but we considered a protein phosphatase as the 
most likely target. Phosphorylation of both Thr-174 and Tyr-176 within the activation loop of 
Hog1 is necessary for activity, so de-phosphorylation of either residue is sufficient for 
inactivation. Hog1 is known to be downregulated by the Tyr-specific phosphatase Ptp2 and to a 
lesser extent Ptp3 (Jacoby, Flanagan et al. 1997; Wurgler-Murphy, Maeda et al. 1997). Thus we 
considered Ptp2 as the most likely target for Hog1 regulation. In this scenario Hog1 might 
phosphorylate and activate Ptp2, which could in turn de-phosphorylate and inactivate Hog1 
(Fig. 3.1E, Model I). The model equations that govern this system are provided in the 
Supplemental Data. Mathematical analysis of the model revealed that this mechanism can 
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indeed account for the transient activation of Hog1, as measured by phospho-Hog1 
immunoblotting. Figure 3.1F shows a comparison of simulated (line) and 
experimentally-measured (symbols) time series for phospho-Hog1 abundance at each of three 
different salt concentrations tested. According to this model phospho-Hog1 rises rapidly, and 
this is followed by a gradual increase in phospho-Ptp2 to levels sufficient to deactivate the 
pathway and restore phospho-Hog1 to near basal levels. Moreover, this model requires that 
phosphorylation increases Ptp2 phosphatase activity by 100-fold. We consider this large 
effective increase in activity to be plausible given that Ptp2 is predominantly nuclear 
(Mattison, Spencer et al. 1999) and only interacts with phospho-Hog1 after the kinase is 
activated and translocates from cytoplasm to the nucleus (Ferrigno and Silver 1999; Mattison 
and Ota 2000). However, deletion of the PTP2 gene produces only a modest increase in 
phospho-Hog1 and no change in the temporal behavior of Hog1 phosphorylation (Fig. 3.1D)
(Jacoby, Flanagan et al. 1997; Wurgler-Murphy, Maeda et al. 1997). These data suggest that 
regulation of Ptp2 activity is not responsible for rapid pathway deactivation. In striking 
contrast, Hog1 phosphorylation was dramatically increased and prolonged when the kinase 
was mutationally inactivated (Fig. 3.1C) . 
Thus while Model I invoked Hog1 activation of a negative regulator, we next 
considered an alternative model in which Hog1-mediates inactivation of a positive regulator 
(Fig. 3.1E, Model II). We again assumed phosphorylation by Hog1 activates a phosphatase, 
but one acting on a component earlier in the pathway such as the MAP kinase kinase Pbs2. 
To simplify our analysis we did not explicitly model the step involving Hog1 
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phosphorylation of the phosphatase. Rather the dephosphorlation rate of the upstream kinase 
was assumed to be proportional to the amount of phospho-Hog1 (see Supplemental Data). 
This approximation assumes a single rate-limiting step in the negative feedback loop. That is, 
either phosphorylation of the phosphatase or dephosphorylation of the intermediate kinase is 
rate limiting. 
Mathematical analysis of this system reveals that it is not capable of generating a 
phospho-Hog1 response that is transient and that returns to near-basal levels within 30 
minutes of stimulation (Fig. 3.1F, Model II and Supplemental Data). This is because 
deactivation of Hog1 requires that the intermediate kinase also return to a near baseline level 
of activity. Because the unphosphorylated kinase is immediately available to undergo another 
round of phosphorylation, a return to baseline requires that phospho-Hog1 levels remain 
elevated to counteract the effect of the incoming signal. Indeed, this is how Model I works 
except that it is the phosphorylated phosphatase levels that remain high. Relaxation of the 
assumption of a single rate-limiting step in the negative feedback loop does not improve the 
model. This is because counteracting the effect of the signal still requires maintaining 
elevated levels of phosphorylated phosphatase, which in turns requires elevated levels of 
phospho-Hog1. In fact, explicitly including a phosphatase in the model introduces a delay in 
a negative feedback loop making the pathway more susceptible to sustained oscillations in 
Hog1 activity. Given that this model fails to capture the observed behavior of the system, we 
eliminated Model II from further consideration. 
Model I illustrated that deactivation of the pathway can occur if Hog1 activates a 
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phosphatase that in turn acts on Hog1. However, our experimental investigations did not 
support this mechanism. Mathematical analysis also revealed that Hog1 activation of a 
phosphatase for some intermediate kinase does not restore phospho-Hog1 to its basal level. 
Therefore, we decided to investigate other possible upstream mechanisms that might underlie 
the experimentally-observed deactivation of the osmotic stress response. The third 
mechanism we considered is one in which pathway deactivation occurs through 
desensitization of an upstream component. That is, rather than dephosphorylating an 
intermediate kinase, which is then poised to go through another  phosphorylation cycle, 
phosphorylation by Hog1 causes a pathway component to enter a desensitized state in which 
it is no longer available for signaling. For example if the target of Hog1 is assumed to be the 
osmosensor Sho1, then the substrate can exist in a desensitized state (“Sho1-”), in addition to 
the active (“Sho1*”) and inactive (“Sho1”) states. The mathematical equations that describe 
this model, and the assumptions used to derive those equations, are given in the 
Supplemental Data.  
We initially tested a model in which the desensitized component acts directly on Hog1 
(e.g. the MAP kinase kinase Pbs2). Surprisingly, while this model is capable of capturing the 
rapid return of phospho-Hog1 to near basal levels, it could not capture the range of responses 
seen at the different salt concentrations.  In particular, when the model faithfully reproduced 
the robust response at 1 M salt, it was not sensitive enough to respond to the low salt 
concentration of 0.25 M. This led us to speculate that desensitization occurs at another 
upstream component. This would have the effect of introducing a time delay between 
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Fig. 3.2 Activation of Hog1 leads to 
an attenuated response to a 
subsequent stimulus.
To refine the computational model, 
ssk1 cells were treated twice with the 
same dose of KCl either (A) 30 min 
apart or (B) 60 min apart, and cell 
lysates were then resolved by 10% 
SDS-PAGE and immunoblotting (IB) 
with anti-phospho p38 and anti-Hog1 
antibodies. Scanning densitometry of 
experimental data (symbols) were 
plotted together with simulated data 
from model III (lines). The 
densitometry data was scanned from 
two independent experiments and 
averaged. The simulations were done 
by Marcelo Behar and Dr. Tim 
Elston.
pathway desensitization and diminished Hog1 phosphorylation and thereby increase pathway 
sensitivity to low levels of stimulation.  To model this effect we introduced an additional 
kinase component positioned between Hog1 and its substrate.  Mathematical analysis of this 
model is more complicated than for the other cases, but as shown in Fig. 3.1F the model 
succeeds in capturing the time-dependent behavior of Hog1. These results suggest that a 
feedback control mechanism, in which an upstream component of the pathway is 
phosphorylated and desensitized by Hog1, could underlie the transient behavior of the 
pathway. Once again the model is not restricted to a particular target and requires only that it 
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be upstream of both Hog1 and Pbs2. Sho1 was deemed the likely target because it is the 
earliest known component of the pathway.  Stell was considered an unlikely target because 
it is also a component of the Fus3 and Kss1 signaling pathways, which are normally 
unaffected by salt stimulation. This supposition was tested experimentally (see below).
As shown in Fig. 3.1F, Model III accurately captures the temporal behavior of Hog1 
activity. In fitting the model to the data, we made several simplifying assumptions to reduce 
the number of free parameters (see Supplemental Data). Even with the reduced parameter set, 
however, several of the model parameters are not well constrained by the data. Therefore to 
further constrain the model and test its validity, we performed additional experiments in 
which cells were stimulated repeatedly with salt. Cells were treated with either 0.25 M or 0.5 
M KCl, and then with a second identical treatment after 30 min (Fig. 3.2A) or 1 h (Fig. 3.2B). 
Surprisingly, the second dose produced an increase in phospho-Hog1 that was more transient 
and only slightly greater than the first (despite a doubling of the final salt concentration). 
Moreover, the activity was substantially less than that observed with a single high dose 
treatment (compare Fig. 3.2 and Fig. 3.1B). When Model III was fit to these new data, we 
nevertheless observed that it accurately predicted the amplitude and duration of activity at 
each time point (Fig. 3.2). 
Phosphorylation of Sho1
Model III predicts that Hog1 phosphorylates and desensitizes a component in the 
pathway upstream of Pbs2. We considered Sho1 to be the most likely substrate since it is the 
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Fig. 3.3. Sho1 is phosphorylated 
by Hog1 at Ser166. 
(A) To determine if Sho1 is 
phosphorylated, plasmid pRS315 
containing a C-terminal FLAG-tagged 
form of the protein (Sho1-FLAG) was 
expressed in sho1 (WT) or isogenic 
pbs2 or hog1 mutant cells and 
treated with 0.5 M KCl for 15 min, as 
indicated (+). Sho1-FLAG was 
immunopurified (IP) and resolved by 
10% SDS PAGE and immunoblotting 
(IB). To confirm that the slower 
migrating form of the protein is 
phosphorylated, immunopurified Sho1 
was treated with  protein phosphatase, 
either in the presence or absence of 
phosphatase inhibitor. (B) To confirm 
that phosphorylation occurs at Ser-166, this residue as well as all other MAP kinase consensus sites 
(Thr-10, Ser-149, and Thr-184) were replaced with Ala, either alone or in combination. Cultures were 
treated with KCl, immunopurified and resolved by immunoblotting, as described above. (C) To determine 
if Hog1 phosphorylates Sho1 directly, Sho1-FLAG and Sho1S166A-FLAG (negative control) were 
immunopurified from a sho1 pbs2 mutant strain (to block basal phosphorylation) and mixed with 
recombinant Hog1 or the catalytically inactive Hog1K52R (negative control) purified from E. coli. Sho1 
phosphorylation was monitored by immunoblotting as described above. Note that a very faint band 
comigrating with the phosphorylated form of Sho1 could be detected with longer exposures in all lanes; 
however this band is likely non-specific since it was not altered by KCl treatment, by deletion of HOG1 or 
PBS2, or by Ala substitution of all four MAP kinase consensus sites (not shown).
earliest known component in the pathway. Additionally, whereas Hog1 phosphorylation 
normally returns to pre-stress levels within about 30 min, this occurs more slowly in 
SHO1-deficient cells than in wild-type or SLN1-deficient cells (Vandenbol, 1989). These 
temporal differences suggest that feedback inhibition targets some component that is unique to 
the Sho1 branch of the pathway if not Sho1 itself. 
In order to determine if Sho1 is phosphorylated, we performed large-scale purification 
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of a functional C-terminally FLAG-tagged version of the protein, expressed in either osmotic 
stress-stimulated or unstimulated cells. The purified Sho1-FLAG was subsequently analyzed 
by SDS-PAGE, in-gel protease digestion, and mass spectrometry. By this approach, Sho1 was 
unambiguously identified by mass fingerprinting as well as by tandem mass spectrometry 
sequencing (data not shown). In addition, results from tandem mass spectrometry analysis of 
Sho1-specific peptides revealed phosphorylation at Ser-166. This modification was only 
detected in protein from osmotic stress-stimulated cells, and occurs within a MAP kinase
consensus site (Ser or Thr followed by Pro) (data not shown). (The mass spectrometric 
analysis was conducted by Matthew Torres and Dr. Christoph Borchers.) 
To quantitatively monitor Sho1 phosphorylation we immunopurified Sho1-FLAG from 
stress-stimulated and unstimulated cells. Sho1 was then resolved by SDS-PAGE and 
immunoblotting using an anti-FLAG antibody. As shown in Fig. 3.3, Sho1 normally migrates 
at ~45 kDa, while a second ~47 kDa species accumulated in the stress-stimulated cells. Many 
phosphorylated proteins migrate anomalously on SDS-PAGE, so the appearance of a higher 
molecular weight species suggested that a significant proportion of Sho1 was phosphorylated, 
and that phosphorylation is stimulus-dependent. To confirm that the mobility shift was due to 
phosphorylation we treated immunopurified Sho1 with  phosphatase prior to immunoblot 
analysis; under these conditions the mobility shift was eliminated. The effect of phosphatase 
treatment was reversed by the simultaneous addition of phosphatase inhibitors. Thus Sho1 
appears to undergo stimulus-dependent phosphorylation in vivo.
To determine whether Hog1 kinase activity is needed for Sho1 phosphorylation, we 
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monitored the phosphorylation-dependent mobility shift in cells lacking known components 
of the Hog1 signaling pathway. As shown in Fig. 3.3A, Sho1 failed to undergo 
stress-dependent phosphorylation in cells lacking Hog1, as well as in cells lacking the MAP 
kinase kinase Pbs2, which is specifically required for Hog1 activation. Therefore, 
phosphorylation of Sho1 is contingent on Hog1 function. 
To confirm that phosphorylation occurs on Ser-166, we replaced this residue with Ala. 
As shown in Fig. 3.3B, the Sho1S166A mutant failed to undergo a mobility shift in response to 
osmotic stress. These data suggest that Ser-166 is the primary site of MAP kinase 
phosphorylation in vivo. In addition to Ser-166 however there are three other MAP kinase
consensus sites within Sho1. As an additional control, we substituted all three of these other 
candidate sites (Thr-10, Ser-149 and Thr-184) and showed that the triple Ala mutation does 
not alter the mobility shift in response to pathway activation (Fig. 3.3B). These data indicate 
that phosphorylation of Ser-166 fully accounts for the stress-dependent change in Sho1 
electrophoretic mobility. 
To rule out the possibility that Sho1 is phosphorylated by an unknown kinase that is
itself activated by Hog1, we monitored phosphorylation of Sho1 using purified recombinant 
Hog1 in an in vitro kinase reaction. N-terminally GST-tagged Hog1 was purified from 
bacteria, and FLAG-tagged Sho1 was purified from yeast. When combined with purified and 
activated Hog1, Sho1 underwent the same phosphorylation-dependent mobility shift as 
observed in vivo (Fig. 3.3C). Phosphorylation required Hog1 kinase activity, since the 
mobility of Sho1 was unaltered by the catalytically-inactive mutant Hog1K52R. Likewise, the 
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Fig. 3.4. Phosphorylation at Ser-166 
diminishes Sho1 oligomerization.
(A) To obtain sufficient Sho1 for 
mass spectrometry analysis, 
Sho1-FLAG was immunopurified, 
resolved by 10% SDS PAGE, and 
detected by protein staining. The native 
species (Sho1) was determined by mass 
spectrometry to be phosphorylated at 
Ser-166 (data not shown). The high 
molecular species (Sho1 oligomers) 
were shown by mass spectrometry 
sequencing to represent Sho1. The SDS 
PAGE was run by Dr. Stephen 
Parnell. The mass spectrometric 
analysis was conducted by Matthew 
Torres and Dr. Christoph Borchers. 
(B) To confirm that Sho1 forms a 
homo-oligomer, sho1 mutant cells 
were transformed with plasmid pRS315 
containing Sho1-FLAG, pRS316 
containing Sho1-Myc, or both (each 
expressed using the native promoter), 
detergent-solubilized, immunopurified 
(IP), and resolved by 10% SDS PAGE 
and immunoblotting (IB). To confirm 
that Sho1 oligomers formed prior to cell disruption, lysates containing Sho1-Myc alone and Sho1-FLAG
alone were mixed, and then detergent solubilized and immunopurified as described above. Note that 
Sho1-Myc, like Sho1-FLAG, migrates as a doublet following an osmotic stress (data not shown). (C) To 
determine the effect of osmotic stress on Sho1 oligomerization, sho1 or sho1 hog1K52R mutant cells 
expressing plasmid-borne Sho1-FLAG and/or Sho1-Myc were treated with KCl and subjected to 
immunopurification and immunoblot analysis as described above. (D) To determine if phosphorylation at 
Ser-166 affects oligomerization of Sho1, the residue was replaced with Glu (mimics phosphorylated Ser), 
Ala, or Cys (not shown). Cells expressing plasmid-borne wild-type or Sho1 mutants were treated with KCl
and subjected to immunopurification and immunoblot analysis as described above.
mobility of the Sho1 phosphorylation-site mutant (Sho1S166A) was unchanged following 
incubation with active Hog1. Taken together, these results demonstrate unequivocally that 
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Sho1 is phosphorylated by Hog1 directly, and that Hog1 phosphorylation occurs at Ser-166.
Homo-oligomerization of Sho1
In the course of our large-scale purification of Sho1 we detected a ladder of high 
molecular species by SDS-PAGE (Fig. 3.4A); such laddering is often observed for 
membrane-bound proteins that exist as oligomers. Mass spectrometric sequencing of these 
high molecular weight species indicated that they were in fact Sho1. 
To establish whether Sho1 exists as an oligomeric complex, we immunopurified the 
protein and tested for co-association with additional Sho1 proteins. To distinguish the 
purified and co-purifying forms of the protein, FLAG- and Myc-tagged Sho1 were 
co-expressed (both under the control of the native promoter) in a sho1 mutant. Sho1-FLAG 
was then purified using an anti-FLAG affinity resin, and any co-precipitating Sho1-Myc was
detected using an anti-Myc antibody. By this approach Sho1-Myc specifically associated 
with purified Sho1-FLAG (Fig. 3.4B); conversely, Sho1-FLAG specifically associated with 
purified Sho1-Myc (data not shown). In contrast, no complex was detected if Sho1-Myc and 
Sho1-FLAG were combined after cell lysis, thereby excluding the possibility that oligomers 
form during the course of purification (Fig. 3.4B). 
Sho1 binds directly to at least two protein kinases (Ste11 and Pbs2) and thus has many 
characteristics of a kinase scaffold protein (Zarrinpar A 2004). Similarly, Ste5 functions as a 
protein kinase scaffold in the pheromone response pathway and has likewise been shown to 
exist as a homo-oligomer (Yablonski, Marbach et al. 1996; Inouye, Dhillon et al. 1997; Feng, 
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Song et al. 1998). Moreover, previous results showed that Ste5 oligomerization is enhanced 
following pheromone activation (Wang and Elion 2003). Thus we considered whether Sho1 
oligomerization might also be regulated in a stimulus- or phosphorylation-dependent manner. 
As shown in Figs. 3.4B and 3.4C, Sho1 oligomerization was diminished following an 
osmotic stimulus. In contrast, Sho1 oligomerization was unaffected in cells that express the 
catalytically inactive Hog1K52R mutant, which cannot phosphorylate Sho1 (Fig. 3.4C). 
Moreover, whereas immunopurified Sho1-FLAG migrated as a doublet (representing the 
phosphorylated and unphosphorylated species) the co-purifying pool of Sho1-Myc migrated 
as a single band corresponding exclusively to the unphosphorylated species (Figs. 3.4B and 
3.4C) . Collectively, these results suggest that it is the unphosphorylated form of Sho1 that 
assembles into an oligomeric complex and that phosphorylation diminishes Sho1 oligomer 
formation. 
We then investigated whether phosphorylation of Ser-166 specifically was responsible 
for the loss of Sho1 oligomerization. To this end, we co-expressed mutants of Sho1-FLAG 
and Sho1-Myc in which the phosphorylation-site was replaced with Glu (Sho1 S166E). 
Substitution with a negatively-charged amino acid will in many cases mimic the activity of 
the phosphorylated residue. In this instance the Sho1S166E mutants failed to form a stable 
complex when purified using either the FLAG affinity resin (Fig. 3.4D) or the Myc affinity 
resin (data not shown). Notably, substitution of Ser-to-Ala or Ser-to-Cys also inhibited 
oligomer formation (Fig. 3.4D, and data not shown). One explanation for this finding is that 
Ser-166 constitutes part of the Sho1-Sho1 binding interface, and any alteration of this site 
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diminishes protein-protein interaction. In any case, these data indicate that Sho1 
oligomerization is impaired when Ser-166 is modified, either through phosphorylation or 
mutagenesis.
We also considered whether any other conserved domains in Sho1 are required for 
oligomer formation. Sho1 contains at least two protein binding motifs, a Pro-rich domain 
(residues 9-14 “???????) and an SH3 domain (residues 306–367). We tested whether either 
of these motifs is required for oligomerization by introducing substitution mutations in the 
conserved prolines (Sho1P11A/P14A) or in a conserved Trp-338 within the SH3 domain 
(Sho1W338F) (Zarrinpar A 2004). None of these mutations altered Sho1 oligomer formation 
(data not shown).
Sho1 might also form an oligomer through some bridging protein. To explore this 
possibility we examined oligomerization in strains lacking pathway components shown 
previously to bind Sho1; in addition to Ste11 and Pbs2, osmolarity-sensing appears to be 
mediated in part by a single-transmembrane-spanning domain protein Msb2 (O'Rourke SM 
2002; Cullen PJ 2004; Zarrinpar A 2004). None of the corresponding deletion mutants altered 
Sho1 oligomerization in any way (data not shown). Thus Sho1 appears to form a
homo-oligomer at the cytoplasmic binding interface where Ser-166 is located.
Functional characterization of Sho1 phosphorylation
As shown above Hog1 phosphorylation is normally transient but becomes prolonged 
when the kinase is mutationally inactivated (Fig. 3.1C). Our data also show that Hog1 
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Fig. 3.5. Loss of Sho1 phosphorylation and 
oligomerization leads to diminished 
activation of Hog1. To determine the 
functional consequences of Sho1 
phosphorylation and de-oligomerization, 
sho1 ssk1 hog1K52R mutant cells were 
transformed with plasmid pRS315 expressing 
Sho1-FLAG (panels A and B),
Sho1S166E-FLAG (panel A), Sho1S166A-FLAG 
(panel B), or Sho1S166C-FLAG (not shown) 
and treated with 0.5 M KCl for the times 
indicated. Pathway activation was monitored 
by 10% SDS-PAGE of whole cell lysates followed by immunoblotting (IB) with anti-phospho p38 and 
anti-Hog1 antibodies, as described above.
phosphorylates Sho1, and phosphorylation leads to diminished oligomer formation. Thus we 
investigated whether feedback phosphorylation of Sho1 by Hog1 leads to an attenuated 
osmotic-stress response. To this end, we monitored pathway activity using 
anti- phospho-MAP kinase antibodies in cells that express either (i) the phospho-mimic 
mutant Sho1S166E, (ii) the unphosphorylated (but oligomerization-deficient) mutant Sho1S166A, 
or (iii) the unphosphorylated and fully oligomerized wild-type protein. All three forms of 
Sho1 were expressed in a Hog1K52R mutant strain, which was necessary to eliminate feedback 
phosphorylation of wild-type Sho1 (recall that this mutant also exhibits prolonged activation 
in the absence of feedback inhibition). As shown in Fig. 3.5, Sho1S166E strongly diminished 
the amplitude and duration of Hog1 activation, in comparison with wild-type Sho1. This 
result demonstrates that Ser-166 phosphorylation contributes to the transient behavior of the 
pathway. Sho1S166A likewise diminished pathway activation, in the manner of the Sho1S166E
mutant. Since Sho1S166A is neither phosphorylated nor competent to form oligomers, we 
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conclude that loss of oligomerization is sufficient to attenuate the signal. Thus our results 
satisfy a key prediction of the computational model; specifically, that feedback 
phosphorylation leads to desensitization of the Hog1 signaling pathway. Moreover Hog1 
phosphorylates Sho1 directly, and phosphorylation triggers a loss of Sho1-oligomerization 
and a diminished ability to transmit the salt-stress signal.
Discussion
A common phenomenon in biology is that cellular responses wane over time despite 
the presence of a sustained stimulus (Dohlman 2002). Familiar examples include 
desensitization to light, odors, and chemical stimulants such as caffeine or epinephrine. 
Generally speaking, desensitization entails some form of feedback inhibition, where a 
downstream effector alters the activity an upstream transducer. For example in yeast, cell 
surface pheromone receptors are rapidly phosphorylated and endocytosed following 
stimulation, and these events limit the ability of the receptor to transmit the signal. Such 
phosphorylation-mediated negative feedback mechanisms do not require new protein 
synthesis and therefore can act rapidly, sometime within seconds of pathway activation. 
Other mechanisms can take hours or even days. For instance in the pheromone response 
pathway a number of negative regulators are transcriptionally induced by pheromone, 
including the RGS protein Sst2 and the MAP kinase phosphatase Msg5 (Roberts, Nelson et 
al. 2000). Increased transcription of a negative regulator could certainly limit pathway 
activation, but would most likely occur over the relatively long time needed for protein 
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synthesis to occur. Thus in any given system there can be multiple overlapping mechanisms 
of desensitization, each with distinct kinetics of induction, that collectively modulate cellular 
responsiveness to a given stimulus. 
Much of our previous work has focused on regulation of the pheromone response 
pathway and the MAP kinase Fus3. However our broader research interest is in the molecular 
mechanisms of desensitization. Here we have turned our attention to desensitization of the 
high osmolarity signaling pathway leading to Hog1. The Sho1-branch is of particular interest 
because sustained osmotic stimulation leads to unusually transient activity. Our hope was that 
by examining desensitization of the Hog1 pathway, commonalities would emerge that might 
be applicable to other MAP kinase pathways. 
To accomplish our goals, we began with a simple model of the Sho1 branch of the 
pathway. Mathematical modeling predicted feedback phosphorylation of an early component, 
possibly Sho1 itself. While it has been suggested that Hog1- dependent activation or induction 
of the phosphatase Ptp2 might account for the observed transient behavior (Wurgler-Murphy, 
Maeda et al. 1997), our analysis demonstrated that Ptp2 regulates pathway intensity but not 
temporal changes in pathway activation (Fig. 3.1D) [see also (Klipp E 2005)]. Rather, our 
model suggested that temporal control of signaling occurs primarily upstream of Hog1.
Sho1 was deemed a likely target for several reasons. First, our mathematical analysis 
revealed that for the computational model to reproduce the observed temporal behavior of 
phospho-Hog1, feedback inhibition has to occur at least two components upstream of the 
MAP kinase. Second, Sho1 is the earliest known component of the pathway, and therefore 
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well positioned to regulate signal input. Sho1 is located at the plasma membrane, and genetic 
evidence places Sho1 upstream of all other Hog1-pathway components (Posas and Saito 1997; 
Reiser, Salah et al. 2000). Third, another well-characterized MAP kinase in yeast (Fus3) has 
been shown to phosphorylate several early activators and regulators, including the RGS 
protein Sst2 (Parnell SC 2005 ), the MAP kinase kinase Ste7 (Zhou, Gartner et al. 1993; 
Maleri, Ge et al. 2004), and the kinase scaffold protein Ste5 (Flotho A 2004). Fourth, the 
temporal differences in deactivation of the Sln1- vs. Sho1-branch suggest that rapid feedback 
inhibition occurs on some component that is unique to the Sho1 branch of the pathway. Indeed, 
Sho1 was postulated previously to be a substrate for Hog1, and that feedback phosphorylation 
in such case might confer pathway specificity or in some way dampen cross talk with the 
pheromone signaling pathway (O'Rourke and Herskowitz 1998). These precedents led us to 
focus our investigations on Sho1.
Our experimental analysis led to a series of discoveries: First, we determined that Sho1 
is phosphorylated by Hog1. Sho1 is the first upstream component of the osmotic 
stress-response pathway identified as a substrate for Hog1. Second, we determined that Sho1 
exists normally as a homo-oligomer. Third, we determined that phosphorylation leads to a 
loss of Sho1 oligomerization. Since phosphorylation or mutational substitution of Ser-166 
impairs Sho1-Sho1 interaction, we propose that position 166 constitutes part of the 
Sho1-Sho1 binding interface, and that unmodified Ser-166 is required for oligomer formation.
Finally, we determined that phosphorylation-promoted loss of Sho1 oligomerization leads to 
diminished Hog1 activation. Collectively, the available data suggest the following model of 
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Fig. 3.6. Mechanism of Sho1 activation and inactivation. Sho1 exists as an oligomer, designated 
[(Sho1)2], which upon osmotic stress becomes activated (Sho1*) and competent to transmit a signal 
leading to Hog1. Activated Hog1 phosphorylates Sho1 (P-Sho1) and promotes the transition from an 
oligomeric to a monomeric form of the protein. This physical transition attenuates the capability of Sho1 
to activate Hog1. This diagram was contributed by Marcelo Behar.
Sho1 activation and inactivation (Fig. 3.6): (i) Sho1 exists as an oligomer, which upon 
osmotic stress activates a kinase cascade culminating with Hog1, (ii) activated Hog1 
phosphorylates Sho1 and promotes a transition from the oligomeric to a monomeric form of 
the protein, and (iii) this physical transition attenuates the capability of Sho1 to activate 
Hog1. 
The events described here have significant parallels in the pheromone response pathway. 
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Like Sho1, the pheromone receptor Ste2 and the kinase scaffold protein Ste5 each form stable 
homo-oligomers (Yablonski, Marbach et al. 1996; Inouye, Dhillon et al. 1997; Feng, Song et al. 
1998; Overton and Blumer 2000; Yesilaltay and Jenness 2000). Moreover, Ste5 
oligomerization appears to be regulated by pheromone (Wang and Elion 2003). Like Sho1, 
Ste5 mutants that are unable to oligomerize fail to transmit the pheromone signal (Inouye, 
Dhillon et al. 1997; Feng, Song et al. 1998). Although Ste2 and Ste5 are both phosphorylated 
in response to pheromone stimulation, however, in neither case has phosphorylation been 
shown to regulate oligomer formation.
Our computational analysis also provides new insights into feedback regulation of 
biological systems. Our models indicate that it is far more effective to inhibit an activator 
than to activate an upstream inhibitor. For example, phosphatases are unsatisfactory targets of 
feedback regulation, since the targeted kinase can still be re-phosphorylated and re-activated 
and a very large increase of phosphatase activity would be needed to noticeably dampen 
signaling. Moreover, if phosphatase activity is contingent on the MAP kinase, that kinase 
would have to retain partial activity in order to maintain full phosphatase function. In contrast, 
feedback phosphorylation leading to desensitization of upstream activators provides a more 
efficient and effective means of pathway regulation. 
The ability to deactivate the pathway at the level of the “receptor” has at least two 
additional advantages for the system. First if there are components shared among multiple 
signaling pathways (e.g. Ste11) then deactivation of the receptor allows those components to 
remain competent to transmit signals from other receptors. Second, regulation of an early 
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component in a multi-component signaling cascade will increase the sensitivity of the system 
by creating a delay between the feedback phosphorylation event early in the pathway and 
deactivation of the MAP kinase late in the pathway. Such a delay allows the cell to 
desensitize to strong signals yet remain sensitive enough to detect weak signals. 
Multi-component signaling cascades are well known to confer signal amplification. We 
propose that multi-component signaling cascades also allow cells to respond appropriately to 
a wide range of signal strengths.
We believe that analysis of feedback regulation in yeast might provide insights into the 
mechanism of signal desensitization in higher eukaryotic organisms. A long-term goal is to 
develop similar computational models of osmo-adaptation in humans. A validated model of 
the high osmolarity pathway in yeast demonstrates the feasibility of the approach, and will 
facilitate similar efforts to model more complex biological pathways. Quantifying biological 
systems and accurately predicting cellular processes could eventually guide development of 
new therapies for stress-induced pathologies, such as reperfusion injury after organ 
transplantation, cardiac arrest, and shock.
Experimental Procedures
Strains and Plasmids
Standard methods for the growth, maintenance, and transformation of yeast and bacteria 
and for the manipulation of DNA were used throughout. All mutations were constructed using 
the QuikChange site-directed mutagenesis kit (Stratagene) according to the manufacturer's 
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directions. All plasmid open reading frames constructed in this study were sequenced. The 
yeast S. cerevisiae strains used were BY4741 (MATa leu20 met150 his31 ura30) 
(Research Genetics, Huntsville, AL) or BY4741-derived deletion mutants lacking sho1, ssk1, 
hog1, pbs2, ste11, msb2, sho1/msb2 (sho1::HIS3, msb2::KanMX), sho1/ste11(sho1::HIS3, 
ste11::KanMX), sho1/pbs2 (sho1::HIS3, pbs2::KanMX), sho1/ssk1 (sho1::HIS3, 
ssk1::KanMX), sho1/hog1 (sho1::HIS3, hog1::KanMX), ssk1/hog1K52R (ssk1::KanMX), 
ssk1/sho1/hog1K52R (ssk1::KanMX, sho1::HIS3). 
Plasmid pRS316-SHO1 was constructed by subcloning a BamHI-BamHI fragment 
containing the SHO1 open reading frame plus 600 bp upstream and downstream,
PCR-amplified using primers SHO1-1-5’ and SHO1-2-3’ (See Supplementary Data Table S4),
and introduced into pRS316. pRS316-SHO1::HIS3 was constructed by subcloning a
SacI-SacI HIS3 fragment PCR-amplified from pRS313 using primers HIS3-1-5’ and 
HIS3-1-3’, and inserted into the SacI site within the SHO1 open reading frame in
pRS316-SHO1. The plasmid was then digested with BamHI, transformed into yeast, and 
plated onto SCD–HIS selective medium. The gene deletion was further confirmed by PCR 
and diminished cell growth on salt-containing medium.
Expression plasmid pRS315-SHO1- FLAG was constructed as follows. STE4 was 
PCR-amplified using primers STE4-1-5’/STE4-FLAG-1-3’ or STE4-1-5’/STE4-Myc-1-3’,
and subcloned into the BamHI site of pRS315-ADH or pRS316-ADH (ADH1 promoter and 
terminator). The STE4 sequence was removed by XmaI digestion (artificial site contained 
within the PCR primers) to yield pRS315-ADH-FLAG or pRS316-ADH-Myc. A
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BamHI-XmaI fragment containing the SHO1 promoter and open reading frame was 
PCR-amplified using primers SHO1-1-5’ and SHO1-1-3’, introduced into pRS316, and then 
subcloned into pRS315-ADH-FLAG digested with XbaI and XmaI. A KpnI-XmaI fragment 
containing the SHO1 promoter and open reading frame was PCR-amplified using primers 
SHO1-2-5’  and SHO1-1-3’and introduced into pRS316-ADH-Myc. Note that the native 
SHO1 promoter and not the plasmid-borne ADH1 promoter was used for expression. 
Plasmid pGEX-2T6-HOG1 was constructed by PCR amplification of HOG1 or 
hog1K52R (from strain WL001:SO317 in the EG123 strain background, provided by Wendall 
A. Lim, Univ. California) using primers HOG1-1-5’ and HOG1-1-3’, and cloned into the 
BamHI site of pGEX-2T (Amersham) and pRS306 to yield pRS306-hog1K52R. 
pRS306-hog1K52R was linearized with MscI, transformed into yeast, and plated onto
SCD–URA selective medium followed by 5’FOA-containing medium. The gene deletion was 
further confirmed by PCR and diminished cell growth on salt-containing medium.
Large- Scale Purification From Yeast Cells
Yeast cells were grown in selective SCD medium to A600 nm ~ 1.0. Salt treatments were 
done by dilution of a 2.5 M stock solution of KCl in growth medium. Note that KCl was used 
instead of NaCl, since sodium replaces potassium in some biomolecules and therefore 
stimulates detoxification responses unrelated to Hog1 signaling (Hohmann 2002). A total of 
10 l of cells were collected using ice-cold tubes containing NaN3 (5 mM final) and 
centrifuged at 500 xg for 10 min. Cell pellets were immediately frozen and stored at –80 °C. 
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All subsequent procedures were conducted at 4 °C unless otherwise indicated. Cells were 
resuspended in 200 ml IP lysis buffer (50 mM NaPO4 pH 7.5, 400 mM NaCl, 1% Triton 
X-100, 10% glycerol, 25 mM NaF, 25 mM -glycerophosphate, freshly prepared 1 mM 
NaVO3, 100 µg/ml phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, protease inhibitor 
mixture (1873580, Roche Applied Science), and aliquoted into ~ 100 1.5 ml microfuge tubes. 
Each tube was subjected to glass bead homogenization 6 times for 1 min each. Cell lysates 
were then rocked for 1 h to further solubilize membrane-bound proteins, and centrifuged at 
90,000 xg for 1 h. The supernatant was transferred to a clean 250 ml Nalgel (31410250, 
Fisher Scientific) bottle and mixed with 200 µl of a 50% slurry of EZviewTM Red anti-FLAG 
M2 affinity gel (SL04473, Sigma) equilibrated in IP lysis buffer. After 3 h of gentle agitation, 
the affinity gel was collected by centrifugation at 500 xg for 5 min, washed 4 times with 25 
ml IP lysis buffer, by centrifugation at 500 xg for 5 min for each wash, loaded onto a compact 
reaction column (13928, USB Corporation) and washed once with 3 ml IP lysis buffer. 
FLAG-tagged protein was eluted twice with 200 µl lysis buffer containing 0.5 mg/ml 3x 
FLAG peptide ( F4799, Sigma) with gentle shaking for 15 min, and then precipitated with ~8 
volumes cold acetone at –20°C for 16 h.
Mass Spectrometry
The acetone-precipitated protein pellet was resuspended in 1x LDS (Lithium Dodecyl 
Sulfate) PAGE loading buffer, heated to 95 °C for 10 min, and resolved on a 4-12% gradient 
Bis-Tris NuPAGE precast gel (Invitrogen). The gel was fixed for 30 min in 10% methanol, 
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7% acetic acid followed by a 16 h incubation with SYPRO Ruby protein gel stain (Molecular 
Probes) at room temperature. Individual bands corresponding to Sho1-FLAG were excised 
from the gel and subjected to manual in-gel proteolysis with porcine trypsin (Promega) as 
described previously (Borchers, Peter et al. 2000), followed by analysis using matrix-assisted 
laser desorption ionization (MALDI) time-of-flight mass spectrometry. Excised peptides 
were dissolved in 50% methanol, 0.1% formic acid and then 1/5 of this solution was 
crystallized 1:1 with MALDI matrix (-cyano-4-hydroxycinnamic acid in 50% acetonitrile, 
0.1% trifluoroacetic acid) and analyzed on a 4700 MALDI-TOF/TOF mass spectrometer 
(Applied Biosystems) operated in either MS or tandem MS mode.
TCA Acid Extraction of Protein for Immunoblot Analysis
A total of 20 ml cell culture at A600 nm ~ 1.0 was collected by centrifugation at 500 xg for 
1 min at 4 °C and cell pellets were stored frozen at -70 °C. Cells were later thawed on ice and 
resuspended in 300 µl TCA buffer (10 mM Tris-HCl pH 8.0, 10% trichloroacetic acid, 25 
mM NH4OAc, 1 mM Na2EDTA) and subjected to glass bead vortex homogenization 5 times 
for 1 min each, and chilled for 3 min between each vortexing step. All subsequent procedures
were conducted at 4 °C unless otherwise indicated. The cell lysates were transferred to a new 
microfuge tube on ice and centrifuged for 10 min at 16,000 x g at 4 °C. The supernatant was 
removed and the pellet was resuspended in 150 µl resuspension solution (100 mM Tris-HCl 
pH 11.0, 3% SDS). The sample was boiled for 5 min and centrifuged for 30 sec at 16,000 xg
to remove the insoluble material. The supernatant was transferred to a new microfuge tube 
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and the protein was quantified using the Bio-Rad DC Protein Assay Kit for samples that 
contain detergent. 2x SDS PAGE sample buffer was added to the protein extract, boiled for 5 
min, and resolved by 10% SDS-PAGE and immunoblotting with anti-p38 antibodies at 1:500
(9211L, Cell Signaling Technologies), anti-Hog1 (yC-20) antibodies at 1:100 (sc-6815, Santa 
Cruz Biotechnology), anti-Myc antibodies at 1:1,000 (9E10 monoclonal cell culture 
supernatant), or anti-FLAG antibodies at 1:1000 (F-3165, Sigma). Immunoreactive bands 
were detected using horseradish peroxidase-conjugated goat anti-mouse IgG or anti-rabbit 
IgG (Bio-Rad) in conjunction with enhanced chemiluminescence (Amersham Biosciences) 
according to the manufacturer's instructions.
Immunopurification
Yeast cells were grown in selective SCD medium to A600 nm ~ 1.0, and then collected into 
ice-cold tubes containing NaN3 (5 mM final) and centrifuged at 500 xg for 5 min. Cell pellets 
were immediately frozen and stored at -80°C. All subsequent procedures were conducted at 4 
°C. A total of 400 A600 nm units of cells were resuspended in 500 µl IP lysis buffer (50 mM 
NaPO4 pH 7.5, 400 mM NaCl, 1% Triton X-100, 10% glycerol, 25 mM NaF, 25 mM 
-glycerophosphate, freshly prepared 1 mM NaVO3, 100 µg/ml phenylmethylsulfonyl 
fluoride, 1 mM dithiothreitol, protease inhibitor mixture (1873580; Roche Applied Science), 
followed by glass bead vortex homogenization 5 times for 1 min each. Cell lysates were 
subsequently rocked for 1 h to further solubilize membrane proteins. The samples were then 
centrifuged at 10,000 x g for 10 min, and the resulting supernatant was incubated with 40 µl 
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of a 50% slurry of EZviewTM Red anti-FLAG M2 affinity gel (Sigma) equilibrated in IP lysis 
buffer. After 2 h of gentle agitation, the gel was centrifuged at 500 xg for 30 sec and washed 
three times with IP lysis buffer. For phosphatase treatment, the gel was washed twice with 
-protein phosphatase reaction buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 2 mM DTT, 
0.1 mM EGTA, 0.01% Brij 35 and incubated with 50 µl -protein phosphatase reaction 
buffer (or -protein phosphatase reaction buffer with phosphatase inhibitor 10 mM NaVO3
and 50 mM NaF) with 0.5 µl -protein phosphatase (P0753S, New England Biolabs) at 30 °C
for 30 min. After phosphatase treatment the gel was centrifuged at 500 xg for 30 sec and
washed once with IP lysis buffer. Elution of FLAG-tagged protein was achieved by 
incubating the gel with 50 µl elution buffer (50 mM NaPO4 pH 7.5, 150 mM NaCl) 
containing 0.5 mg/ml of 3x FLAG peptide and shaking gently for 30 min. The eluted protein 
was collected after centrifugation at 8,000 xg for 30 sec and resolved by SDS-PAGE and 
immunoblotting as described above.
Purification of GST-MAP Kinases and in vitro Phosphorylation Assays
The purified recombinant GST-Hog1 and GST-Hog1K52R, as well as yeast-purified 
Sho1-FLAG substrate, were used in an in vitro kinase assay as described previously (Parnell 
SC 2005 ).
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Supplemental data
Mathematical Modeling 
In this section we present details of the three mathematical models described in the text 
for feedback inhibition in the Sho1 osmotic stress- response pathway. 
Model I - Phosphatase inhibition of Hog1
In this model feedback inhibition occurs when phospho-Hog1 phosphorylates and 
activates an unspecified phosphatase (for the purpose of discussion we use Ptp2). The 
phosphatase is then able to more efficiently dephosphorylate phospho-Hog1. The variables 
considered in this model are the phospho-Hog1 concentration, [P-Hog1] and the 
phospho-phosphatase concentration, [P-Ptp2]. The system was modeled using 
Michaelis-Menten kinetics for each phosphorylation/dephosphorylation cycle. Because 
pathway activation and deactivation occur within 30 min, we did not include protein 
synthesis or degradation in the model. The model consists of the following set of differential 
equations: 
1
1
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2 3
(1 [P-Hog1])d[P-Hog1]
dt (1 [P-Hog1])
[P-Ptp2][P-Hog1](1 [P-Ptp2])[P-Hog1]
(1 [P-Ptp2]) [P-Ptp2]
k s
Km
kk
Km Km
  = + 
   + +  + 
(11)
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4 5
[P-Ptp2][P-Hog1](1 [P-Ptp2])d[P-Ptp2]
dt (1 [P-Ptp2]) [P-Ptp2]
kk
Km Km
 = +  +
(12)
where s is the salt concentration, the ki’s are the maximum reaction velocities, and the Kmi’s 
are the Michaelis-Menten constants. In the above equations all the concentrations have been 
scaled by the total concentration of the respective protein. For example, the total Hog1 
concentration is given by [Hog1]T = [P-Hog1] + [Hog1] and the concentration in Eq. (11)
represents the quantity (phospho-Hog1 concentration)/[Hog1]T. Table S1 contains the 
parameter values used to produce Fig. 3.1F in the text. Figure 3.S1 shows a plot of the 
time-dependent [P-Hog1] versus the time-dependent [P-Ptp2]. Also shown are the nullclines 
(i.e. the curves defined by d[P-Hog1]/dt = 0 and d[P-Ptp2]/dt = 0). The [P-Hog1] nullcline is 
shown for two different salt concentrations (0.18 M and 0.50 M).  The intersections of the 
nullclines correspond to steady states of the system for the two different salt concentrations. 
This figure, often referred to as a phase plane, demonstrates the mechanism responsible for 
the transient response in this model. For the lower salt concentration the system is in the 
steady state in which both [P-Hog1] and [P-Ptp2] are present at low levels. The addition of 
salt shifts the [P-Hog1] nullcline to the right. This causes a rapid phosphorylation of Hog1 
and the trajectory quickly moves to the new [P-Hog1] nullcline. The elevated level of 
[P-Hog1] causes a slow increase in [P-Ptp2]. The model’s ability to reproduce the 
experimentally observed pathway deactivation requires that phospho-Ptp2 is a very efficient 
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Figure 3.S1. The phase plane for Model I. 
This figure shows the phospho-Hog1 concentration [P-Hog1] plotted as a function of the 
phospho-Ptp2 concentration [P-Ptp2] (long dashed line). Also shown are the nullclines for [P-Hog1] (solid 
line) and  [P-Ptp2] (short dashed line) for two different salt concentrations. Where the nullclines cross 
represents steady states of the system. The simulations were done by Marcelo Behar and Dr. Tim 
Elston.
phosphatase for Hog1 (over 100 more efficient then unphosphorylated Ptp2). Therefore a 
modest rise in [P-Ptp2] is sufficient to return [P-Hog1] to near basal levels. 
Model II - Phosphatase inhibition of an intermediate kinase
This model is similar to Model I except that the phosphatase dephosphorylates and 
inactivates an intermediate upstream kinase K (i.e., Ste11 or Pbs2). The concentration [P-K] 
denotes the phosphorylated form of the intermediate kinase. To simplify the analysis, we 
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assumed that the feedback loop consists of a single rate limiting step. That is, either the rate 
of phosphorylation of the phosphatase by phospho-Hog1 or the rate of dephosphorylation of 
the intermediate kinase by the phosphorylated phosphatase occurs rapidly. Within this 
approximation, the rate of dephosphorylation of the intermediate kinase can be taken to be 
proportional to the phospho-Hog1 concentration. Phospho-Hog1 dephosphorylation occurs 
through a constitutively active phosphatase. As in the previous model, we assume 
phosphorylation/dephosphorylation reactions follow Michaelis-Menten kinetics and we do 
not consider protein turnover. The equations describing the system are:
3 4
3 4
[P-K] (1 [P-Hog1]) [P-Hog1]d[P-Hog1]
dt (1 [P-Hog1]) [P-Hog1]
k k
Km Km
   = +  +
(13)
d[P-K]
dt
= k1[Sho1*](1 [P-K])
Km1 + (1 [Sho1*])
 k2 [P-K]
Km2 + [P-K]
+ k5 [P-Hog1][P-K]
Km5 + [P-K]




(14)
Again the concentrations have been scaled by the total protein amounts. The parameter 
values used to produce Fig. 3.1F are given in Table S2. As can be seen from Fig. 3.1F, the 
model is unable to produce the return of phospho-Hog1 to a near basal level in the presence 
of a sustained stimulus. This is because deactivation of phospho-Hog1 requires that the 
intermediate phospho-kinase also return to a near basal level. Because the unphosphorylated 
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Figure 3.S2. The steady state values of the phospho-Hog1 concentration as a function of the salt 
concentration. 
Note that in both Models I and II the steady phospho-Hog1 concentration depends linearly on the salt 
concentration, whereas the steady states of Model III show a weaker dependence on salt. The simulations 
were done by Marcelo Behar and Dr. Tim Elston.
kinase is immediately available to go through another round of phosphorylation, to bring the 
unphosphorylated kinase back to its basal level requires that phospho-Hog1 levels remain 
elevated to counteract the effect of the signal. Fig. 3.S2 summarizes the steady state behavior 
of all the models as a function of the salt concentration. As can be seen, in Model II the 
steady-state concentration rises much more rapidly than for the other two models.  For 
comparison with Model I, the time-dependent response of Model II is summarized in Fig. 
3.S3. In this figure [P-Hog1] is plotted versus [P-K]. Again the nullclines for both 
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Figure 3.S3. The phase plane of Model II. 
This figure shows the phospho-Hog1 concentration [P-Hog1] plotted as a function of the 
phophorylated intermediate kinase concentration [P-K] (long dashed line). Also shown are the nullclines 
for [P-Hog1] (short-dashed line) and  [P-Ptp2] (long-dashed line) for two different salt concentrations.
The simulations were done by Marcelo Behar and Dr. Tim Elston.
concentrations are shown. 
To simplify the analysis of Model II, we made the assumption that the negative feedback 
loop containes a single rate-limiting step. Relaxing this assumption by explicitly including 
the phosphatase for the intermediate kinase in the model does not improve its ability to 
capture the return of phospho-Hog1 to a near basal level. This is because counteracting the 
effect of the signal still requires maintaining elevated levels of phospho-phosphatase, which 
in turns requires elevated levels of phospho-Hog1. 
92
Model III – Desensitization of an upstream activator
We next investigated a mechanism in which pathway deactivation occurs through 
desensitization of an upstream element. That is, rather than dephosphorylating an 
intermediate kinase, which is then poised to go through another phosphorylation cycle, 
phosphorylation by Hog1 causes a pathway component to enter a desensitized state in which 
it is no longer available for signaling. As described in the text, this mechanism can account 
for all the experimental data if it is assumed that at least one pathway component lies 
between Hog1 and the component that is feedback phosphorylated.  If we assume 
desensitization occurs at the level of the osmosensor Sho1, let [Sho1*] denote the 
concentration of activated protein and let [Sho1-] denote the concentration of desensitized 
protein, the following set of equations describe the system:
3 4
3 4
[P-K] (1 [P-Hog1]) [P-Hog1]d[P-Hog1]
dt (1 [P-Hog1]) [P-Hog1]
k k
Km Km
   = +  +
(15)
d[P-K]
dt
= k7[Sho1*](1 [P-K])
Km7 + (1 [Sho1*])
 k8 [P-K]
Km8 + [P-K]
(16)
--
5 6
-
5 6
[P-Hog1] [Sho1*] [Sho1 ]d[Sho1 ]
dt [Sho1*] [Sho1 ]
k k
Km Km
  = + +
(17)
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d[Sho1*]
dt
= k1  s  (1 [Sho1*] [Sho1
-])
Km1 + (1 [Sho1*] [Sho1-])
 k2 [Sho1*]
Km2 + [Sho1*]
 k5 [P-Hog1] [Sho1*]
Km5 + [Sho1*]
(18)
As shown in Figs. 3.1F, 2A and 2B, this model can account for all the experimental 
observations. The parameter values found from fitting the model to the experimental data are 
given in Table S3. Because this model contains four equations it is considerably more 
difficult to analyze than the first two. However, Fig. 3.S2 illustrates that the steady-state 
phospho-Hog1 concentration only depends weakly on the signal, thereby allowing 
phospho-Hog1 concentration to return to a near basal level in the presence of a sustained 
signal.
Parameter Value
k1 9.3 x 10-3 
Km1 1.4 x 10-01
k2 3.4 x 10-03
Km2 6.6 x 10-01
k3 1.0
Km3 2.2 x 10-03
k4 7.3 x 10-06
Km4 1.8 x 10-01
k5 1.3 x 10-05
Km5 6.3 x 10-02
Table S1. Parameter values for Model I. The simulations were done by Marcelo Behar and Dr. Tim 
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Elston.
Parameter Value
k1 1.1 x 10-2 
Km1 1.5
k2 0
Km2 N/A*
k3 1.5 x 10-02
Km3 5.8 x 10-02
k4 3.3 x 10-04
Km4 5.9 x 10-02
k5 8.6 x 10-03
Km5 3.2 x 10-03
Table S2. Parameter values for Model II.
*
 The best fit to the data occurs when k2 is zero. Therefore the Michaelis-Menten constant for this reaction 
is undetermined. The simulations were done by Marcelo Behar and Dr. Tim Elston.
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Parameter Value
k1 4.1 x 10-3 
Km1 7.6 x 10-01
k2 1.8 x 10-03
Km2 2.1
k3 3.6 x 10-02
Km3 1.2 x 10-02
k4 3.0 x 10-04
Km4 1.6 x 10-03
k5 5.6 x 10-03
Km5 5.8 x 10-04
k6 8.8 x 10-04
Km6 1.0 x 10-01
k7 3.5 x 10-01
Km7 4.5 x 10-01
k8 3.4 x 10-02
Km8 10.0 x 10-02
Table S3. Parameter values for Model III. The simulations were done by Marcelo Behar and Dr. Tim 
Elston.
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Name Sequence
STE4-1-5’ GGATCCCGGGACGATGGCAGCACATCAGATGGAC
STE4-FLAG-1-3’ GGATCCAATCTTATCGTCGTCATCCTTGTAATC
CCCGGGTTGATAACCTGGAGACCATATTTTC
STE4-Myc-1-3’ GGATCCCTACAAATCTTCTTCAGAAATCAATTTTTGTTC
CCCGGGTTGATAACCTGGAGACCATATTTTC
SHO1-1-5’ CGCGGATCCGGAACTGAGCACAAGACAGCCGTGCCATTGACG
SHO1-1-3’ CCCCCCGGGACGATGCATTTCTTCTGGACCATCG
SHO1-2-5’ GGGGTACCGGAACTGAGCACAAGACAGCCGTGCCATTGACG
SHO1-2-3’ CGCGGATTCGCCGCCTCTTTAGGTGACATGGTTATGGCCACTG
HOG1-1-5’ CGCGGATCCATGACCACTAACGAGGAATTCATTAGGACAC
HOG1-1-3’ CGCGGATCCTTACTGTTGGAACTCATTAGCGTACTGTATGGCC
HIS3-1-5’ CGAGCTCCGTTTTAAGAGCTTGGTGAGCGC
HIS3-1-3’ CGAGCTCCGCGCCTCGTTCAGAATGACAC
Name Sequence*
sho1T10A GTCAATATCATCAAAGATAAGACCGGCGCCTCGTAAACCTTCACGTATGGCTACC
sho1S149A GGCGGTGATAATGCTGCCCCAACCAATAGATGG
sho1S166A CCATTAAGGGTATCAGGCCTGCGCCATTAGAGAATTCTC
sho1T184A GCTCGTCGAAGAGGCAATAGGAACACGGCGCCTTACCAAAATAATGTCTATAATGATG
sho1S166E CCATTAAGGGTATCAGGCCTGAGCCATTAGAGAATTCTC
sho1S166C CCATTAAGGGTATCAGGCCTTGCCCATTAGAGAATTCTC
sho1P11A/P14A CAAAGATAAGACCAACTGCTCGTAAAGCTTCACGTATGGCTACC
sho1W338F CTCTGACATTGAAGGCAGATTCTGGAAGGCAAGAAGGGC
*The complementary primers are not shown.
Table S4. Oligonucleotides used for PCR amplification and mutagenesis.
CHAPTER 4. REGULATION OF MAPK SIGNALING FIDELITY 
BY FEEDBACK PHOSPHORYLATION
Abstract
Distinct environmental signals will often use common signaling proteins to achieve very 
different physiological outcomes. The mating and invasive-growth pathways require distinct 
effector MAPKs (Fus3 and Kss1, respectively) yet they are activated by a common set of 
upstream kinases (Ste11 and Ste7). We conducted a quantitative analysis of MAPK activity 
and devised a series of computational models that describe their activity in vivo. As 
anticipated by one of the models, Fus3 phosphorylation of the upstream MAPK kinase (Ste7) 
leads to diminished signaling by Kss1. These findings reveal how feedback phosphorylation 
can lead to altered signal specificity, and demonstrate how computational and experimental 
approaches, used in an integrated fashion, can reveal new mechanisms to ensure signal 
pathway fidelity in vivo.
Introduction
One measure of our understanding of any biological system is the ability to predict its 
behavior in detail. One aspect of this endeavor is to model signal transduction events, which 
are defined here as the dynamic changes that occur within a cell in response to external 
stimuli (Riccobene, Omann et al. 1999; Shea, Neubig et al. 2000; Bhalla, Ram et al. 2002).  
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Such models can help us to understand how small changes outside a cell produce strongly 
amplified effects within a cell (Hao, Yildirim et al. 2003), how graded signals are converted 
to all-or-none responses (Ferrell and Machleder 1998), or how transient external signals are 
prevented from being propagated indefinitely (Bhalla and Iyengar 1999). Here we consider 
how activation of one signaling pathway leads to the simultaneous inactivation of a second 
pathway. The experimentally observed behavior is described quantitatively by computational 
modeling, and the various models are then evaluated experimentally yielding a fully 
validated consensus model.
For these studies we investigated a developmental switch in the budding yeast 
Saccharomyces cerevisiae. Yeast cells can initiate either a mating or invasive growth program, 
depending on the presence or absence of specific external cues. Mating is initiated when a
and  haploid cell types secrete and respond to cell-type specific pheromones acting through 
G protein-coupled receptors, whereupon a and  cells fuse to form an a/ diploid. 
Alternatively, invasive or filamentous growth occurs in nutrient-poor conditions and is 
manifested by altered budding, formation of long branching filaments, as well as increased 
adherence and invasion of the substratum. 
The mating pheromone pathway in yeast is perhaps the best-characterized signal 
transduction system in any eukaryote, and it has long served as a prototype for hormone, 
neurotransmitter and sensory response systems in humans (Dohlman and Thorner 2001). 
Moreover, disruption or activation of pathway components is easily achieved, and these 
alterations lead to highly specific changes that can be easily quantified. Previously, combined 
99
genetic and biochemical studies revealed that mating requires a protein kinase cascade 
comprised of Ste20, Ste11, Ste7 and Fus3 (Rhodes, Connell et al. 1990; Gartner, Nasmyth et 
al. 1992; Leberer, Dignard et al. 1992; Errede, Gartner et al. 1993; Zhou, Gartner et al. 1993). 
Analogous approaches revealed that most of the same components are also required by the 
invasive growth pathway; the pathways diverge at the level of the MAPK, in which case
Kss1 becomes activated in place of Fus3 (Liu, Styles et al. 1993; Roberts and Fink 1994). 
Moreover, the kinase activity of Kss1 increases filamentation, while the activity of Fus3 
suppresses filamentation (Roberts and Fink 1994; Cook, Bardwell et al. 1997; Madhani and 
Fink 1997; Roberts, Nelson et al. 2000; Sabbagh, Flatauer et al. 2001). 
While the mechanisms of MAPK activation are well established, less understood is 
how signaling pathways that share the same components can attain such different 
developmental fates (Elion, Qi et al. 2005). Signal identity has been ascribed to differences in 
signal magnitude, duration, and frequency (Bhalla, Ram et al. 2002), as well as to the 
scaffolded association of protein kinase components (Pawson and Scott 1997). The findings 
presented here reveal that Fus3-mediated phosphorylation of Ste7 leads to diminished 
activation of Kss1, and this trans-regulatory mechanism contributes to the developmental 
switch from the invasive to the mating differentiation program. Significantly, these 
experimental findings were predicted by detailed computational models that describe the 
behavior of cells treated with pheromone. The demonstrated predictive power of these 
models illustrates the utility of coordinated computational and experimental approaches to 
important biological questions.
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Results
Recent experiments in yeast have suggested that pathway specificity occurs at the level 
of the MAPK (Sabbagh, Flatauer et al. 2001). Fus3 is the primary MAPK required for mating 
while Kss1 activation is required for invasive growth. Paradoxically, both MAPKs are 
activated by Ste7; moreover, stimulation by pheromone causes phosphorylation of both Fus3 
and Kss1. However, Kss1 activation has been reported to be transient while Fus3 activity is 
more sustained (Sabbagh, Flatauer et al. 2001). Because transient activation of Kss1 by 
pheromone is evidently not sufficient to produce invasive growth, it has been suggested that 
pathway specificity is a dynamic property of the two signaling pathways (Sabbagh, Flatauer 
et al. 2001). Kss1 is also more active in the absence of Fus3 expression, suggesting that Fus3 
limits the ability of Kss1 to transmit a signal (Sabbagh, Flatauer et al. 2001). However, the 
biochemical basis for the negative effect of Fus3 on Kss1 is unknown. 
As described above there are multiple possible mechanisms underlying Kss1 inhibition 
by Fus3. Computational modeling has previously been used to investigate temporal 
regulation of signal transduction pathways. These investigations have delineated the role of 
positive and negative feedback loops in modulating signaling intensity (Hao, Yildirim et al. 
2003). Here we employed computational analysis to delineate mechanisms of signal pathway
specificity. Based on our previous experiences, we anticipated that modeling could help us to 
identify definitive and feasible experiments to address mechanism. Before this can be 
contemplated however, quantitative experimental data are required for use in model 
construction and validation. With this goal in mind, the dose- and time-dependent behavior of 
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Fig 4.1. Time courses for pheromone-stimulated phosphorylation of Fus3 and Kss1 in wild-type cells 
over a range of pheromone concentrations.
To determine the kinetics of Ste7 activation of signaling, wild-type cells were treated with different 
concentrations of  factor pheromone for the times indicated; cell lysates were then resolved by 12% 
SDS-PAGE and immunoblotting (IB) with anti-phospho p42/44 antibodies, which recognize the 
phosphorylated and activated form of Fus3 and Kss1 or with anti- Pgk1 antibodies (loading control).
Scanning densitometry of data were plotted. Blue/red dots/lines represent the intensity relative to the peak 
intensity of each pheromone concentration. Grey dots/lines represent intensity relative to the peak intensity 
of 10µM pheromone concentration. The densitometry data was scanned from four independent 
experiments and averaged. This experiment was done by Michal Nagiec.
Fus3 and Kss1 were analyzed in a variety of genetic backgrounds.
MAPK activation was monitored using phospho-p42/p44 antibodies, which recognize 
the phosphorylated and activated forms of Fus3 and Kss1. Fig. 4.1 shows time courses for 
pheromone-stimulated phosphorylation of Fus3 and Kss1 in wild-type (WT) cells over a 
range of pheromone concentrations. As evident from these data, the levels of phosphorylated 
Kss1 and Fus3 rise rapidly and then decline to near-basal levels within 60 min of stimulation. 
At the highest dose of pheromone tested, however, both Fus3 and Kss1 remained highly
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Fig 4.2. Fus3 inhibits the activation 
of Kss1 in response to pheromone 
stimulation.
To determine the importance of 
Fus3-mediated phosphorylation on 
inhibition of Kss1 activation, cell 
lines in which Fus3 or Kss1 had been 
deleted or 2-fold over expressed or 
cells bearing a catalytically inactive 
gene replacement mutant (fus3K42R)
were treated with 3µM pheromone 
for the times indicated and analyzed 
by immunoblotting (IB) with 
anti-phospho p42/44 antibodies, 
which recognize the phosphorylated 
and activated form of Fus3 and Kss1 
or with anti- Pgk1 antibodies (loading 
control). For 2-fold overexpression, 
cells were transformed with a single 
copy plasmid (pRS316) containing 
genomic FUS3 (2XFUS3) or KSS1 
(2XKSS1). All of the experiments 
were repeated no less than twice. The 
representatives of experiments with 
similar results are shown.
phosphorylated even after 90 minutes. The main difference was in the kinetics of activation, 
with Kss1 becoming fully phosphorylated after 5 min, while Fus3 phosphorylation increased 
more slowly and not peaking until 60 min after the initial stimulus. These findings indicate 
that persistent signaling per se does not account for the developmental switch leading to 
mating. Indeed, the biggest difference between Fus3 and Kss1 was at the earliest time points. 
This early difference in activity implied that the developmental switch decision stems from a 
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short term change such as phosphorylation, and is unlikely to result from longer term effects 
such as alterated gene transcription or protein abundance.
To confirm the importance of Fus3 in regulation of Kss1 activity, MAPK activation 
following pheromone treatment was monitored in cell lines in which either Fus3 or Kss1 had 
been deleted or overexpressed (Fig. 4.2). In this case cells were treated with an intermediate 
dose of pheromone (3 µM), where the largest difference in MAPK activities were likely to 
occur (see Fig. 4.1), and over a slightly longer time period. Consistent with the idea that Fus3 
inhibits Kss1 activation, while deletion of Fus3 (fus3) enhanced Kss1 activation (Fig. 4.2), 
as reported previously (Sabbagh, Flatauer et al. 2001), 2-fold overexpression of Fus3 
(“2xFus3”) diminished Kss1 phophorylation (Fig. 4.2). One possible explanation for these 
findings is that Fus3 competes with Kss1 for access to the upstream MAPK kinase Ste7. In 
such case, competition for binding to Ste7 should occur independently of kinase catalytic 
activity. To test the model we repeated the experiments using a catalytically inactive mutant 
form of Fus3 (Fus3K42R) (Fig. 4.2). However this strain behaved in a manner similar to the
fus3 mutant strain, demonstrating that Fus3 kinase activity is necessary for Kss1 inhibition. 
Likewise, deletion or 2-fold overexpression of Kss1 did not alter pheromone-dependent 
phosphorylation of Fus3 (Fig. 4.2). Thus we considered several alternative and more 
complex models, as detailed below.
Having established that inhibition of Kss1 requires a Fus3-mediated phosphorylation 
event, we next developed six models to describe this inhibition. All six models include the 
known positive regulator (Ste7) and three negative regulators of the pathway (Msg5, Ptp2, 
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and Ptp3). Msg5 is a dual specificity phosphatase (de-phosphorylates Ser, Thr, and Tyr), 
while Ptp2 and Ptp3 act specifically on phospho-Tyr.  All four proteins are known to 
interact with both Kss1 and Fus3. None of the models make any distinction between Fus3 
and the Fus3-Ste5 complex, since Kss1 does not ordinarily bind to Ste5. The models also do 
not explicitly consider pheromone-induced Ste7 activation; rather, two simple scenarios were 
tested. In the first scenario the amount of phosphorylated and activated Ste7 is assumed to 
remain constant throughout the duration of the experiment and enters the models as a free 
parameter. In the second scenario, phosphorylated Ste7 is assumed to decline exponentially 
over the course of the experiment. In the latter case the contribution of Ste7 is described by 
two parameters, the amount of phosphorylated Ste7 at t = 0 and the inactivation rate of 
phosphorylated Ste7. Both scenarios produced qualitatively similar results but the second 
scenario produced a better quantitative fit to the data. Therefore we only present results for 
the second scenario. Stimulation with pheromone is also known to induce the expression of 
Msg5, Fus3 and Kss1. Therefore each model assumes that activation of Fus3 and Kss1 
increase the synthesis rate of all three phosphatases. We observed that Ptp3 degradation 
increases upon pheromone stimulation. Therefore, each model assumes that the induced 
degradation rate of Ptp3 is proportional to the amount of phosphorylated Ste7.  The 
degradation rate of Ptp2 also increases upon pheromone stimulation. However, in contrast to 
Ptp3, the total amount of Ptp2 (phosphorylated and unphosphorylated) remains constant, 
implying that the increase in degradation is offset by increased synthesis (data not shown). 
Thus to simplify the models we assumed that Ptp2 remains constant throughout the 
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experiment. 
We then constructed six different models for Fus3 inhibition of Kss1. A general 
feature of each model is that Fus3 inhibits Kss1 by either activating inhibitors or inhibiting 
activators. Model I assumes that the inhibitory effect of Fus3 on Kss1 is achieved through 
Fus3 transcriptional induction of Msg5, and Fus3 does not alter the activity of the three 
phosphatases or the upstream kinase Ste7. We demonstrated above that Fus3-dependent 
phosphorylation is required for the observed inhibition of Kss1, and that the observed 
differences in Fus3 and Kss1 activity are evident within minutes of pheromone stimulation; 
thus the transcriptional induction of negative regulators could not account for the observed 
regulatory behavior. Thus we included Model I here as a negative control.  Model II 
assumes that Fus3 is required to activate Ptp2 and Ptp3, but Msg5 is constitutively active. 
Model III assumes Ptp2 and Ptp3 are constitutively active and Fus3 is required for activation 
of Msg5. Model IV assumes that Fus3 is required for the activation of all three phosphatases. 
Model V assumes that all three phosphatases are constitutively active and Fus3 acts through 
another mechanism; this model simply assumes that the rate of Kss1 dephosphorylation is 
proportional to the amount of phosphorylated Fus3. Finally, Model VI assumes that Fus3 
phosphorylation of the upstream kinase Ste7 leads to the selective activation of Fus3 rather 
than Kss1. Mathematical models in terms of ordinary differential equations were constructed 
for all six models, as detailed below. 
All computational simulations were performed using Matlab. To fit the models to the 
data we chose a Markov Chain Monte Carlo approach based on the Metropolis algorithm.  
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We chose this method for two reasons. First, because is it a stochastic algorithm it can escape 
local minima in parameter space. Second it provides a measure of model performance with 
perturbations in the parameter values (see below).  All six models were fit to the time 
courses for activated Fus3 and Kss1 obtained from wild-type cells, as well as from cells that 
express an extra copy of Fus3 (2xFus3), that express an extra copy of Kss1 (2xKss1), that 
express a catalytically inactive form of Fus3 (Fus3K42R), that lack Fus3 (fus3) or that lack 
Kss1 (kss1). We obtained the sum of the squared residuals, S, for the 6 models, the 
minimum S obtained from long Markov Chain Monte Carlo analysis for all six models and 
the average value of S (preliminary results not shown).  As can be seen from these 
simulations, Models I, III, IV and V performed poorly, while the two remaining models 
performed equally well in reproducing the experimental data.  Thus we conducted 
additional analysis designed to establish the validity of Models II and VI. 
A good test of any model is its ability to predict the outcome of new experiments. Model 
II and VI each made distinct predictions regarding the role of Ptp2 and Ste7. Whereas Model 
II assumes that Fus3 is required to activate Ptp2 and Ptp3, Model VI assumes that Fus3 
phosphorylates the upstream kinase Ste7 and phosphorylated Ste7 is then less able to activate 
Kss1.
Using the optimal parameter set, Models II and VI were used to predict the outcome of 
time course experiments obtained using cells that express an extra copy of Ptp2 (2xPtp2), an
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Fig 4.3. Model VI captures the 
behavior of the experimental results
of phosphatase or upstream kinase 
mutants. 
To test the validity of Models II
and VI, the time courses of pheromone 
-stimulated phosphorylation of Fus3 
and Kss1 in (a) msg5, ptp2, ptp3
or ptp2/ptp3 strains or (b) wild-type 
strains transformed with a single copy 
plasmid (pRS316) containing genomic 
MSG5 (2XMsg5), PTP2 (2XPtp2), 
PTP3 (2XPtp3) or STE7 (2XSte7), 
treated with 3µM pheromone were 
monitored by immunoblotting (IB) 
with anti-phospho p42/44 antibodies or with anti- Pgk1 antibodies as a loading control.
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extra copy of Ptp3 (2xPtp3), an extra copy of Ste7 (2xSte7), or that lack one or both of these 
phosphatases (ptp2, ptp3, ptp2/ptp3). As shown in Fig 4.3, Model II was not able to 
qualitatively capture the behavior of all the experimental results. Specifically, it 
overestimated the effect of the ptp2 and ptp2/ptp3 mutations on Kss1 activation. In 
contrast, Model VI faithfully captured the behavior of all the experimental results
(preliminary results not shown). 
We then conducted additional experiments to further validate the Model VI. Specifically 
we examined whether feedback phosphorylation of Ste7 by Fus3 indeed diminishes signaling 
through Kss1. It has been shown previously that Ste7 is phosphorylated at multiple sites by 
Fus3 and Kss1. The central prediction of Model VI was that Kss1 activation would be 
elevated in the absence of this MAPK feedback phosphorylation event. Accordingly, we
obtained time course data of activated Fus3 and Kss1 in a Ste7A7 mutant strain, in which Ste7 
lacks all seven feedback phosphorylation sites. As predicted by the model, Kss1 activation 
was dramatically enhanced while Fus3 activation was substantially diminished particularly at 
the 60 min time point (Fig. 4.4A). 
Having shown that Kss1 inhibition occurs mainly through Fus3 dependent inhibition of 
Ste7 action on Kss1, we refit this model to the entire data set including the results for the 
Ste7A7 mutant strains. While our mathematical model is quite simple, it is in excellent 
agreement with the experimental results (preliminary results not shown).
The data presented above reveal that Fus3 inhibits Kss1, and does so through
phosphorylation of Ste7. In the absence of Ste7 phosphorylation, Kss1 is activated 
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Fig 4.4. Feedback phosphorylation of Ste7 by Fus3 inhibits Kss1 activation and the cross-activation 
of the invasive growth pathway in response to pheromone.
(A) To confirm Model VI, ste7 cells were transformed with plasmid expressing STE7 or Ste7A7
and treated with 3µM pheromone for the times indicated. MAPK activation was monitored by 12% 
SDS-PAGE of whole cell lysates followed by immunoblotting (IB) with anti-phospho p42/44 and 
anti-Pgk1 antibodies, as described above.
To determine the functional consequences of Ste7 phosphorylation on crosstalk, (B) ste7 cell was
transformed with plasmid expressing STE7 or Ste7A7. The same cells were co-transformed with 
pRS425-Ty-lacZ, FRE-lacZ reporter. Cells were then incubated in the presence (+pheromone) or absence 
(-pheromone) of the 3µM  factor pheromone for 90 min, and the resulting -galactosidase activity was 
measured spectrofluorimetrically. (C) The MLY218a-ste7 cell was transformed with the plasmid
expressing STE7 or Ste7A7. Cells were spotted onto solid YPD medium and rubbed vigorously under a 
stream of water to detect invasive growth after 2-3 days.
inappropriately by pheromone. Since Kss1 mediates the invasive growth response, loss of
Ste7 phosphorylation should also lead to invasive growth when activated by pheromone. To 
test this prediction, we monitored Kss1-mediated responses in the ste7A7 strain. First, 
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activation of the invasive growth pathway leads to transcription induction of genes under the
control of promoters containing a filamentous-responsive element (FRE). Therefore, an FRE 
(Ty)-lacZ reporter was used to monitor transcription activity in the presence or absence of 
feedback phosphorylation. As shown in Fig 4.4b, the Ste7A7 strain exhibited a significant 
elevation of pheromone-stimulated induction of FRE-lacZ.  Second, we monitored invasive 
growth behavior. Moreover the Ste7A7 strain showed increased invasive growth (Fig. 
4.4c(Maleri, Ge et al. 2004). These results demonstrate that feedback phosphorylation of the 
upstream kinase Ste7 by Fus3 inhibits Kss1 activation, and thereby inhibits crosstalk from 
the pheromone pathway to the invasive growth pathway. In the absence of feedback 
phosphorylation, cells establish an elevated and more sustained Kss1 activation response.
Discussion
Environmental signals are transduced into appropriate cellular responses through 
complex signaling pathways. A common feature of such signaling networks is that they often 
use common proteins to transmit very distinct signals. Therefore a major challenge is to 
understand the biochemical mechanisms that establish pathway specificity. The yeast 
pheromone response and invasive growth pathways provide an excellent example of 
pathways that share components yet produce developmental outcomes that are mutually 
exclusive.
In yeast there are five members of the MAP kinase family, but Fus3 and Kss1 have been 
most extensively characterized. In humans there are 11 MAP kinases that fall into 5 
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subfamilies: (i) ERK1/2, (ii) JNK 1/2/3, (iii) p38, , ,  (iv) ERK5 and (v) ERK7. Splice 
variants of several of the MAPKs further contributes to the complexity of their regulation.  
Several of the MAPKs are ubiquitously expressed yet regulate very specific biological 
responses that differ from cell type to cell type. Signal specificity is derived in part from the 
diversity of upstream activators and their different protein-protein interactions and covalent 
modifications, allowing the integration of specific MAPK pathways in the cellular response 
to diverse stimuli including cytokines, growth factors, antigens, toxins, pharmacological 
drugs, stress insults, as well as changes in extracellular matrix and cell-cell interactions.  
These stimuli initiate distinct developmental outcomes, including cell growth, differentiation 
and apoptosis. 
Clearly the wide range of responses requires strict controls on the duration and intensity 
of signaling. Critical to that control are protein phosphatases that inactivate MAPKs and 
upstream protein kinases that activate MAPKs. Fus3 promotes mating while Kss1 promotes 
invasive growth, although both MAPKs are activated by a common set of upstream kinases 
Ste11 and Ste7. Here we found that phosphorylation of an intermediary MAPK kinase Ste7
by Fus3 leads to diminished signaling via Kss1. This discovery demonstrates how feedback 
phosphorylation can lead to altered signal specificity. Given the parallel of MAPK signaling 
in yeast and mammals, we postulate that pathway signaling specificity is regulated by 
feedback phosphorylation of upstream activators in other systems as well. 
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Experimental Procedures
Strains and plasmids
Standard methods for the growth, maintenance, and transformation of yeast and 
bacteria, and for the manipulation of DNA, were used throughout (Ausubel, Brent et al. 
1987).  The yeast Saccharomyces cerevisiae strains used in this study are BY4741 (MATa
leu2 his3 met15 ura3) or BY4741-derived deletion mutants lacking ste7, fus3, kss1, 
ptp2, ptp3, msg5 or ptp2 /ptp3 (ptp2::URA3, ptp3::KanMX) (Research Genetics, Huntsville, 
AL).  The yeast strain used in the invasive growth assay is the 	1278-based MLY218a-ste7 
(MATa leu2 ura3, ste7::KanMX). 
Expression plasmids used in this study are those containing FUS3, KSS1, PTP2, 
PTP3, and MSG5.  Each gene was amplified using flanking PCR primers that anneal 600 bp 
upstream or 600 bp downstream of the open reading frame.  The PCR products were then 
subcloned by digestion with BamHI (PTP2, PTP3), BamHI+EcoRI (FUS3), NotI+XhoI
(KSS1) or XhoI+KpnI (MSG5) (restriction sites encoded by the PCR primers) and ligation to 
pRS316 and/or pRS305 (for pRS305-PTP2::URA3). 
pRS305-PTP2::URA3 was constructed by subcloning a BglII-BglII URA3 fragment 
PCR-amplified from pRS316 using primers GAA GAT CTG AGA CGG TCA CAG CTT 
GTC TG and GTG TGG CGT CCC ATT ATT GAC GAA GAT CTC ACA CCG CAG GGT 
AAT AAC TG, and inserted into the BglII site within the PTP2 open reading frame of
pRS305-PTP2. The plasmid was then digested with BamHI to liberate the PTP2::URA3
cassette, transformed into yeast, and plated onto SCD–URA selective medium. The gene 
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deletion was further confirmed by PCR.
Expression plasmids encoding STE7 (pNC752) and the feedback 
phosphorylation-deficient ste7A7 mutant (pNC769) were described previously (Maleri, Ge et 
al. 2004).  
TCA Acid Extraction of Protein for Immunoblot Analysis
A total of 20 ml cell culture at A600 nm ~ 1.0 was collected by centrifugation at 500 xg
for 1 min at 4 °C and cell pellets were stored frozen at -70 °C. Cells were later thawed on ice 
and resuspended in 300 µl TCA buffer (10 mM Tris-HCl pH 8.0, 10% trichloroacetic acid, 25 
mM NH4OAc, 1 mM Na2EDTA) and subjected to glass bead vortex homogenization 5 times 
for 1 min each, and chilled for 3 min between each vortexing step. All subsequent procedures
were conducted at 4 °C unless otherwise indicated. The cell lysates were transferred to a new 
microfuge tube on ice and centrifuged for 10 min at 16,000 x g at 4 °C. The supernatant was 
removed and the pellet was resuspended in 150 µl resuspension solution (100 mM Tris-HCl 
pH 11.0, 3% SDS). The sample was boiled for 5 min and centrifuged for 30 sec at 16,000 xg
to remove the insoluble material. The supernatant was transferred to a new microfuge tube 
and the protein was quantified using the Bio-Rad DC Protein Assay Kit for samples that 
contain detergent. 2x SDS PAGE sample buffer was added to the protein extract, boiled for 5 
min, and resolved by 12% SDS-PAGE and immunoblotting with anti-phospho-p42/44
antibodies at 1:500 (9101L, Cell Signaling Technologies), anti-Pgk1 antibodies at 1:10,000. 
Immunoreactive bands were detected using horseradish peroxidase-conjugated anti-rabbit 
IgG (Bio-Rad) in conjunction with enhanced chemiluminescence (Amersham Biosciences) 
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according to the manufacturer's instructions.
Invasive growth and reporter transcription assays
The invasive growth assay and reporter transcription assay were conducted as described 
previously (Maleri, Ge et al. 2004). Unless indicated otherwise, the pheromone concentration 
was 3 µM. The filamentous-responsive element (FRE) transcription reporter (Ty-lacZ) used 
in this study was described previously (Maleri, Ge et al. 2004).
Computational modeling
All computational simulations were performed using Matlab. To fit the models to the 
data we chose a Markov Chain Monte Carlo (MCMC) approach based on the Metropolis 
algorithm (For details see Supplemental Data, in preparation. Not shown in this thesis).  
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